HIV-1	B-protein
Tat	I-protein
potentiates	O
TNF	B-protein
-induced	O
NF-kappa	B-protein
B	I-protein
activation	O
and	O
cytotoxicity	O
by	O
altering	O
the	O
cellular	O
redox	O
state	O
.	O

This	O
study	O
demonstrates	O
that	O
human	B-protein
immunodeficiency	I-protein
virus	I-protein
type	I-protein
1	I-protein
(	I-protein
HIV-1	I-protein
)	I-protein
Tat	I-protein
protein	I-protein
amplifies	O
the	O
activity	O
of	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	O
TNF	B-protein
)	O
,	O
a	O
cytokine	O
that	O
stimulates	O
HIV-1	O
replication	O
through	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
.	O

In	O
HeLa	B-cell_line
cells	I-cell_line
stably	O
transfected	O
with	O
the	O
HIV-1	B-DNA
tat	I-DNA
gene	I-DNA
(	O
HeLa-tat	B-cell_line
cells	I-cell_line
)	O
,	O
expression	O
of	O
the	O
Tat	B-protein
protein	I-protein
enhanced	O
both	O
TNF	B-protein
-induced	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
TNF	B-protein
-mediated	O
cytotoxicity	O
.	O

A	O
similar	O
potentiation	O
of	O
TNF	B-protein
effects	O
was	O
observed	O
in	O
Jurkat	O
T	O
cells	O
and	O
HeLa	B-cell_line
cells	I-cell_line
treated	O
with	O
soluble	O
Tat	B-protein
protein	I-protein
.	O

TNF	B-protein
-mediated	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
cytotoxicity	O
involves	O
the	O
intracellular	O
formation	O
of	O
reactive	O
oxygen	O
intermediates	O
.	O

Therefore	O
,	O
Tat	B-protein
-mediated	O
effects	O
on	O
the	O
cellular	O
redox	O
state	O
were	O
analyzed	O
.	O

In	O
both	O
T	B-cell_type
cells	I-cell_type
and	O
HeLa	B-cell_line
cells	I-cell_line
HIV-1	B-protein
Tat	I-protein
suppressed	O
the	O
expression	O
of	O
Mn-dependent	B-protein
superoxide	I-protein
dismutase	I-protein
(	O
Mn-SOD	B-protein
)	O
,	O
a	O
mitochondrial	B-protein
enzyme	I-protein
that	O
is	O
part	O
of	O
the	O
cellular	O
defense	O
system	O
against	O
oxidative	O
stress	O
.	O

Thus	O
,	O
Mn-SOD	B-protein
RNA	O
protein	O
levels	O
and	O
activity	O
were	O
markedly	O
reduced	O
in	O
the	O
presence	O
of	O
Tat	B-protein
.	O

Decreased	O
Mn-SOD	B-protein
expression	O
was	O
associated	O
with	O
decreased	O
levels	O
of	O
glutathione	O
and	O
a	O
lower	O
ratio	O
of	O
reduced	O
:	O
oxidized	O
glutathione	O
.	O

A	O
truncated	O
Tat	B-protein
protein	I-protein
(	O
Tat1-72	B-protein
)	O
,	O
known	O
to	O
transactivate	O
the	O
HIV-1	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
,	O
no	O
longer	O
affected	O
Mn-SOD	B-protein
expression	O
,	O
the	O
cellular	O
redox	O
state	O
or	O
TNF	B-protein
-mediated	O
cytotoxicity	O
.	O

Thus	O
,	O
our	O
experiments	O
demonstrate	O
that	O
the	O
C-terminal	B-protein
region	I-protein
of	O
HIV-1	B-protein
Tat	I-protein
is	O
required	O
to	O
suppress	O
Mn-SOD	B-protein
expression	O
and	O
to	O
induce	O
pro-oxidative	O
conditions	O
reflected	O
by	O
a	O
drop	O
in	O
reduced	O
glutathione	O
(	O
GSH	B-protein
)	O
and	O
the	O
GSH	O
:	O
oxidized	O
GSH	O
(	O
GSSG	O
)	O
ratio	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	NULL
EMBO	NULL
Journal	NULL
vol	NULL
.	NULL

14	NULL
no.3	NULL
pp.546-554	NULL
,	NULL
1995	NULL
HIV-1	NULL
Tat	NULL
potentiates	NULL
TNF-induced	NULL
NF-xB	NULL
activation	NULL
and	NULL
cytotoxicity	NULL
by	NULL
altering	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
Michael	NULL
O.Westendorp	NULL
'	NULL
,	NULL
Vladimir	NULL
A.Shatrov	NULL
'	NULL
,	NULL
Klaus	NULL
Schulze-Osthoff	NULL
,	NULL
Rainer	NULL
Frank	NULL
,	NULL
Margot	NULL
Kraft®	NULL
,	NULL
Marek	NULL
Los	NULL
,	NULL
Peter	NULL
H.Krammer	NULL
'	NULL
,	NULL
Wulf	NULL
Droge*	NULL
and	NULL
Volker	NULL
Lehmann	NULL
?	NULL

*	NULL
Divisions	NULL
of	NULL
'Immunogenetics	NULL
and	NULL
``	NULL
Immunochemistry	NULL
,	NULL
German	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
D-69120	NULL
Heidelberg	NULL
and	NULL
Center	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Heidelberg	NULL
,	NULL
D-69120	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
Corresponding	NULL
author	NULL
M.O.Westendorp	NULL
and	NULL
V.A.Shatrov	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
study	NULL
Communicated	NULL
by	NULL
G.Himmerling	NULL
This	NULL
study	NULL
demonstrates	NULL
that	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
Tat	NULL
protein	NULL
amplifies	NULL
the	NULL
activity	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
,	NULL
a	NULL
cytokine	NULL
that	NULL
stimulates	NULL
HIV-1	NULL
replication	NULL
through	NULL
activation	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
.	NULL

In	NULL
HeLa	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
HIV-1	NULL
tat	NULL
gene	NULL
(	NULL
HeLa-tat	NULL
cells	NULL
)	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
Tat	NULL
protein	NULL
enhanced	NULL
both	NULL
TNF-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
TNF-mediated	NULL
cytotoxicity	NULL
.	NULL

A	NULL
similar	NULL
potentiation	NULL
of	NULL
TNF	NULL
effects	NULL
was	NULL
observed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
Hela	NULL
cells	NULL
treated	NULL
with	NULL
soluble	NULL
Tat	NULL
protein	NULL
.	NULL

TNF-mediated	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
cytotoxicity	NULL
involves	NULL
the	NULL
intracellular	NULL
formation	NULL
of	NULL
reactive	NULL
oxygen	NULL
inter-mediates	NULL
.	NULL

Therefore	NULL
,	NULL
Tat-mediated	NULL
effects	NULL
on	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
were	NULL
analyzed	NULL
.	NULL

In	NULL
both	NULL
T	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
HIV-1	NULL
Tat	NULL
suppressed	NULL
the	NULL
expression	NULL
of	NULL
Mn-dependent	NULL
superoxide	NULL
dismutase	NULL
(	NULL
Mn-SOD	NULL
)	NULL
,	NULL
a	NULL
mitochondrial	NULL
enzyme	NULL
that	NULL
is	NULL
part	NULL
of	NULL
the	NULL
cellular	NULL
defense	NULL
system	NULL
against	NULL
oxidative	NULL
stress	NULL
.	NULL

Thus	NULL
,	NULL
Mn-SOD	NULL
RNA	NULL
protein	NULL
levels	NULL
and	NULL
activity	NULL
were	NULL
markedly	NULL
reduced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tat	NULL
.	NULL

Decreased	NULL
Mn-SOD	NULL
expression	NULL
was	NULL
associated	NULL
with	NULL
decreased	NULL
levels	NULL
of	NULL
glutathione	NULL
and	NULL
a	NULL
lower	NULL
ratio	NULL
of	NULL
reduced	NULL
:	NULL
oxidized	NULL
glutathione	NULL
.	NULL

A	NULL
truncated	NULL
Tat	NULL
protein	NULL
(	NULL
Tat	NULL
;	NULL
_	NULL
;	NULL
;	NULL
)	NULL
,	NULL
known	NULL
to	NULL
transactivate	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
no	NULL
longer	NULL
affected	NULL
Mn-SOD	NULL
expression	NULL
,	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
or	NULL
TNF-mediated	NULL
cytotoxicity	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
experiments	NULL
demonstrate	NULL
that	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
HIV-1	NULL
Tat	NULL
is	NULL
required	NULL
to	NULL
suppress	NULL
Mn-SOD	NULL
expression	NULL
and	NULL
to	NULL
induce	NULL
pro-oxidative	NULL
conditions	NULL
reflected	NULL
by	NULL
a	NULL
drop	NULL
in	NULL
reduced	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
and	NULL
the	NULL
GSH	NULL
:	NULL
oxidized	NULL
GSH	NULL
(	NULL
GSSG	NULL
)	NULL
ratio	NULL
.	NULL

They	NULL
further	NULL
imply	NULL
a	NULL
distinct	NULL
mechanism	NULL
of	NULL
Mn-SOD	NULL
suppression	NULL
as	NULL
compared	NULL
with	NULL
HIV-1	NULL
LTR	NULL
transactivation	NULL
by	NULL
Tat	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
Tat	NULL
expressed	NULL
in	NULL
HIV-l-infected	NULL
cells	NULL
and	NULL
Tat	NULL
taken	NULL
up	NULL
by	NULL
non-infected	NULL
cells	NULL
modulates	NULL
TNF	NULL
activity	NULL
by	NULL
altering	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
.	NULL

These	NULL
findings	NULL
may	NULL
be	NULL
relevant	NULL
for	NULL
HIV-1	NULL
replication	NULL
and	NULL
for	NULL
T	NULL
cell	NULL
depletion	NULL
in	NULL
acquired	NULL
immune	NULL
deficiency	NULL
syndrome	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
cytotoxicity/Mn-SOD/NF-xB	NULL
activation/Tat/	NULL
TNF	NULL
546	NULL
Introduction	NULL
The	NULL
Tat	NULL
protein	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
efficient	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

Tat	NULL
acts	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
transactivation	NULL
response	NULL
element	NULL
(	NULL
TAR	NULL
)	NULL
,	NULL
an	NULL
RNA	NULL
stem-loop	NULL
structure	NULL
located	NULL
close	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
HIV-1	NULL
transcripts	NULL
(	NULL
Berkhout	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Dingwall	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Tat	NULL
increases	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
Sharp	NULL
and	NULL
Marciniak	NULL
,	NULL
1989	NULL
;	NULL
Cullen	NULL
,	NULL
1990	NULL
)	NULL
by	NULL
either	NULL
enhanced	NULL
transcriptional	NULL
initiation	NULL
(	NULL
Hauber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Southgate	NULL
and	NULL
Green	NULL
,	NULL
1991	NULL
)	NULL
or	NULL
increased	NULL
transcriptional	NULL
elongation	NULL
(	NULL
Laspia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Feinberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
for	NULL
a	NULL
review	NULL
see	NULL
Frankel	NULL
,	NULL
1992	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
processes	NULL
.	NULL

Tat	NULL
exhibits	NULL
immuno-suppressive	NULL
properties	NULL
and	NULL
inhibits	NULL
antigen-induced	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
Viscidi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Meyaard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
and	NULL
proteins	NULL
is	NULL
influenced	NULL
by	NULL
HIV-1	NULL
Tat	NULL
.	NULL

Thus	NULL
,	NULL
lymphotoxin	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
,	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-2	NULL
and	NULL
IL-6	NULL
genes	NULL
(	NULL
Buonaguro	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Scala	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Westendorp	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
are	NULL
transactivated	NULL
by	NULL
Tat	NULL
,	NULL
and	NULL
collagen	NULL
expression	NULL
in	NULL
glioblastoma	NULL
cells	NULL
is	NULL
increased	NULL
(	NULL
Taylor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Tat	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
suppress	NULL
promoter	NULL
activity	NULL
of	NULL
major	NULL
histo-compatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
I	NULL
genes	NULL
(	NULL
Howeroft	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
to	NULL
decrease	NULL
IL-2	NULL
receptor	NULL
expression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Purvis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
to	NULL
down-regulate	NULL
TNF	NULL
receptor	NULL
surface	NULL
expression	NULL
in	NULL
Raji	NULL
B	NULL
lymphoblastoid	NULL
cells	NULL
(	NULL
Poesik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
HIV-1	NULL
Tat	NULL
is	NULL
secreted	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
and	NULL
can	NULL
be	NULL
taken	NULL
up	NULL
rapidly	NULL
by	NULL
other	NULL
cells	NULL
(	NULL
Cullen	NULL
,	NULL
1986	NULL
;	NULL
Frankel	NULL
and	NULL
Pabo	NULL
,	NULL
1988	NULL
;	NULL
Marcuzzi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Westendorp	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Tat	NULL
can	NULL
potentially	NULL
influence	NULL
cellular	NULL
gene	NULL
expression	NULL
in	NULL
infected	NULL
and	NULL
non-infected	NULL
cells	NULL
.	NULL

TNF	NULL
was	NULL
found	NULL
to	NULL
amplify	NULL
HIV-1	NULL
expression	NULL
in	NULL
chronically	NULL
infected	NULL
T	NULL
lymphocytes	NULL
,	NULL
monocyte	NULL
cell	NULL
lines	NULL
and	NULL
primary	NULL
monocytes	NULL
(	NULL
Folks	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Mellors	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

It	NULL
stimulates	NULL
HIV-1	NULL
replication	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
<	NULL
B	NULL
enhancer	NULL
motifs	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
;	NULL
Duh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
unstimulated	NULL
cells	NULL
,	NULL
NF-xB	NULL
is	NULL
present	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
complexed	NULL
with	NULL
its	NULL
inhibitory	NULL
subunit	NULL
IxB	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

When	NULL
cells	NULL
are	NULL
stimulated	NULL
with	NULL
TNF	NULL
,	NULL
IkB	NULL
rapidly	NULL
dissociates	NULL
from	NULL
the	NULL
inactive	NULL
complex	NULL
.	NULL

This	NULL
process	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
certain	NULL
protein	NULL
kinases	NULL
and	NULL
proteases	NULL
(	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
allows	NULL
translocation	NULL
of	NULL
NF-xB	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
subsequent	NULL
binding	NULL
to	NULL
its	NULL
DNA	NULL
motifs	NULL
(	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
for	NULL
a	NULL
review	NULL
see	NULL
Blank	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
that	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
response	NULL
to	NULL
TNF	NULL
and	NULL
other	NULL
agents	NULL
is	NULL
mediated	NULL
by	NULL
pro-oxidative	NULL
conditions	NULL
(	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Schulze-Osthoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
exogenous	NULL
reducing	NULL
agents	NULL
,	NULL
such	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
as	NULL
N-acetyl-cysteine	NULL
and	NULL
glutathione	NULL
,	NULL
suppressed	NULL
TNF-induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
(	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Mihm	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
HIV-1	NULL
expression	NULL
in	NULL
infected	NULL
Molt-4	NULL
T	NULL
leukemia	NULL
cells	NULL
(	NULL
Roederer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

HIV-1	NULL
infection	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
substantial	NULL
decrease	NULL
in	NULL
CD4+*	NULL
T	NULL
lymphocytes	NULL
(	NULL
Meyaard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
are	NULL
depleted	NULL
by	NULL
apoptosis	NULL
(	NULL
Ameisen	NULL
and	NULL
Capron	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

According	NULL
to	NULL
one	NULL
model	NULL
,	NULL
T	NULL
cells	NULL
are	NULL
primed	NULL
to	NULL
undergo	NULL
apoptosis	NULL
upon	NULL
crosslinking	NULL
of	NULL
CD4	NULL
by	NULL
gp120	NULL
(	NULL
Banda	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Gougeon	NULL
and	NULL
Montagnier	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Subsequent	NULL
activation	NULL
by	NULL
conventional	NULL
antigens	NULL
or	NULL
superantigens	NULL
induces	NULL
apoptosis	NULL
in	NULL
these	NULL
T	NULL
cells	NULL
(	NULL
Ameisen	NULL
and	NULL
Capron	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Both	NULL
TNF	NULL
and	NULL
lymphotoxin	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
course	NULL
of	NULL
the	NULL
HIV-1	NULL
infection	NULL
and	NULL
acquired	NULL
immune	NULL
deficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
TNF	NULL
have	NULL
been	NULL
observed	NULL
in	NULL
sera	NULL
(	NULL
Zauli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
in	NULL
supernatants	NULL
of	NULL
cultured	NULL
monocytes	NULL
(	NULL
Wright	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
Vyakarnam	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
alveolar	NULL
macrophages	NULL
from	NULL
AIDS	NULL
patients	NULL
(	NULL
Krishnan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
an	NULL
abnormal	NULL
cellular	NULL
redox	NULL
state	NULL
contributes	NULL
to	NULL
apoptosis	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
Dréoge	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
and	NULL
that	NULL
TNF	NULL
,	NULL
by	NULL
generating	NULL
oxidative	NULL
stress	NULL
,	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
mediators	NULL
causing	NULL
lysis	NULL
of	NULL
HIV-1-infected	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
Huber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
what	NULL
events	NULL
render	NULL
cells	NULL
susceptible	NULL
to	NULL
the	NULL
cytotoxic	NULL
action	NULL
of	NULL
TNF	NULL
during	NULL
HIV-1	NULL
infection	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
HIV-1	NULL
Tat	NULL
protein	NULL
to	NULL
modulate	NULL
TNF	NULL
activity	NULL
.	NULL

It	NULL
was	NULL
found	NULL
that	NULL
HIV-1	NULL
Tat	NULL
potentiates	NULL
TNF-induced	NULL
NF-	NULL
«	NULL
xB	NULL
activation	NULL
and	NULL
TNF-mediated	NULL
cytotoxicity	NULL
by	NULL
down-regulation	NULL
of	NULL
Mn-dependent	NULL
superoxide	NULL
dismutase	NULL
(	NULL
Mn-SOD	NULL
)	NULL
,	NULL
shifting	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
towards	NULL
pro-oxidative	NULL
conditions	NULL
.	NULL

Thus	NULL
HIV-1	NULL
Tat	NULL
might	NULL
provide	NULL
the	NULL
link	NULL
between	NULL
viral	NULL
infection	NULL
and	NULL
the	NULL
observed	NULL
oxidative	NULL
stress	NULL
and	NULL
consequent	NULL
CD4+*	NULL
T	NULL
cell	NULL
depletion	NULL
in	NULL
AIDS	NULL
.	NULL

Results	NULL
Expression	NULL
of	NULL
HIV-1	NULL
Tat	NULL
potentiates	NULL
TNF-induced	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
TNF-mediated	NULL
cytotoxicity	NULL
To	NULL
explore	NULL
the	NULL
effects	NULL
of	NULL
endogenous	NULL
tat	NULL
expression	NULL
on	NULL
TNF-induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
TNF-mediated	NULL
cytotoxicity	NULL
,	NULL
HeLa	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
tat	NULL
expression	NULL
vector	NULL
were	NULL
employed	NULL
.	NULL

Expression	NULL
of	NULL
Tat	NULL
protein	NULL
was	NULL
evident	NULL
from	NULL
a	NULL
1200-fold	NULL
increase	NULL
of	NULL
HIV	NULL
LTR-directed	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
transfected	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
HeLa	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
monitor	NULL
NF-KB	NULL
activation	NULL
,	NULL
parental	NULL
cells	NULL
and	NULL
HeLa-tat	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
TNF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

After	NULL
30	NULL
min	NULL
,	NULL
cells	NULL
were	NULL
lyzed	NULL
and	NULL
analyzed	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
using	NULL
an	NULL
NF-KB-specific	NULL
P-labeled	NULL
oligonucleotide	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
constitutive	NULL
and	NULL
TNF-induced	NULL
NF-	NULL
«	NULL
xB	NULL
DNA	NULL
binding	NULL
was	NULL
significantly	NULL
elevated	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
in	NULL
comparison	NULL
with	NULL
parental	NULL
cells	NULL
.	NULL

Since	NULL
NF-xB	NULL
was	NULL
reported	NULL
previously	NULL
to	NULL
be	NULL
inhibited	NULL
by	NULL
antioxidants	NULL
(	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Schulze-Osthoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
we	NULL
further	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
antioxidant	NULL
butylated	NULL
hydroxyanisole	NULL
(	NULL
BHA	NULL
)	NULL
on	NULL
Tat-modulated	NULL
NF-xB	NULL
activation	NULL
.	NULL

Parental	NULL
cells	NULL
pretreated	NULL
with	NULL
500	NULL
uM	NULL
BHA	NULL
revealed	NULL
a	NULL
significant	NULL
decrease	NULL
of	NULL
TNF-induced	NULL
NF-KB	NULL
DNA	NULL
binding	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
response	NULL
to	NULL
TNF	NULL
was	NULL
strongly	NULL
Modulation	NULL
of	NULL
TNF	NULL
effects	NULL
by	NULL
Tat	NULL
A	NULL
HeLa	NULL
-|	NULL
HeLa-tat	NULL
ae	NULL
a	NULL
ae	NULL
NF-kB	NULL
-	NULL
ws	NULL
#	NULL
#	NULL
ost	NULL
s	NULL
tod	NULL
«	NULL
-	NULL
«	NULL
-	NULL
«	NULL
©	NULL
int	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5°	NULL
6	NULL
7	NULL
8	NULL
B	NULL
60	NULL
O	NULL
-TNF	NULL
H	NULL
+TNF	NULL
fa	NULL
507	NULL
*€	NULL
.0	NULL
©	NULL
404	NULL
2	NULL
fri	NULL
§	NULL
30	NULL
{	NULL
®	NULL
©	NULL
&	NULL
207	NULL
s	NULL
107	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

TNF-induced	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
HeLa-tat	NULL
and	NULL
parental	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NF-KB	NULL
binding	NULL
activity	NULL
.	NULL

HeLa-tat	NULL
and	NULL
parental	NULL
cells	NULL
(	NULL
1x	NULL
10°	NULL
each	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
6-well	NULL
microtiter	NULL
plates	NULL
overnight	NULL
.	NULL

Then	NULL
BHA	NULL
{	NULL
500	NULL
uM	NULL
)	NULL
and	NULL
subsequently	NULL
TNF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
were	NULL
added	NULL
and	NULL
incubation	NULL
continued	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
NF-KB	NULL
binding	NULL
activity	NULL
in	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NF-xB-dependent	NULL
transactivation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

HeLa	NULL
cells	NULL
or	NULL
HeLa-tat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
4X	NULL
NF-KB/CAT	NULL
construct	NULL
.	NULL

NF-KB	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
TNF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
was	NULL
quantified	NULL
as	NULL
percent	NULL
transacetylation	NULL
.	NULL

Mean	NULL
values	NULL
and	NULL
standard	NULL
deviations	NULL
of	NULL
triplicate	NULL
samples	NULL
are	NULL
given	NULL
.	NULL

inhibited	NULL
by	NULL
BHA	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
but	NULL
was	NULL
still	NULL
stronger	NULL
than	NULL
in	NULL
the	NULL
parental	NULL
cells	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

To	NULL
provide	NULL
evidence	NULL
that	NULL
increased	NULL
NF-xB	NULL
binding	NULL
activity	NULL
was	NULL
also	NULL
reflected	NULL
by	NULL
increased	NULL
NF-KB-mediated	NULL
transcriptional	NULL
activation	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
HeLa	NULL
cells	NULL
and	NULL
HeLa-tat	NULL
cells	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
construct	NULL
carrying	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
NF-KB	NULL
binding	NULL
sequence	NULL
in	NULL
front	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1B	NULL
,	NULL
constitutive	NULL
and	NULL
TNF-induced	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
NF-KB	NULL
transactivating	NULL
activities	NULL
were	NULL
increased	NULL
several-fold	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
parental	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
influence	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
Tat	NULL
on	NULL
TNF-induced	NULL
cytotoxicity	NULL
was	NULL
investigated	NULL
next	NULL
.	NULL

HeLa	NULL
and	NULL
HeLa-tat	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
TNF	NULL
sensitivity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2A	NULL
,	NULL
HeLa-tat	NULL
cells	NULL
were	NULL
more	NULL
susceptible	NULL
to	NULL
the	NULL
cytotoxic	NULL
activity	NULL
of	NULL
TNF	NULL
than	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
.	NULL

To	NULL
kill	NULL
50	NULL
%	NULL
of	NULL
HeLa-tat	NULL
cells	NULL
,	NULL
~100	NULL
times	NULL
less	NULL
TNF	NULL
was	NULL
required	NULL
than	NULL
for	NULL
the	NULL
547	NULL
M.O.Westendorp	NULL
et	NULL
al	NULL
.	NULL

A	NULL
100	NULL
-o-	NULL
Hela	NULL
--	NULL
&	NULL
-	NULL
-	NULL
HeLa-tat	NULL
irs	NULL
80	NULL
2	NULL
S	NULL
a	NULL
60	NULL
a	NULL
40	NULL
20	NULL
0	NULL
0,001	NULL
0,01	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
TNF	NULL
[	NULL
ng/ml	NULL
]	NULL
B	NULL
-o-	NULL
Hela	NULL
100	NULL
-	NULL
&	NULL
--	NULL
-	NULL
HelLa-tat	NULL
80	NULL
€	NULL
2	NULL
eo	NULL
&	NULL
x	NULL
40	NULL
20	NULL
0	NULL
0,001	NULL
0,01	NULL
0,1	NULL
1	NULL
10	NULL
-	NULL
100	NULL
TNF	NULL
[	NULL
ng/ml	NULL
]	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Survival	NULL
and	NULL
growth	NULL
inhibition	NULL
of	NULL
HeLa-tat	NULL
and	NULL
parental	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
TNF	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Survival	NULL
of	NULL
cells	NULL
.	NULL

HeLa-tat	NULL
and	NULL
HeLa	NULL
parental	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
96-well	NULL
plates	NULL
at	NULL
a	NULL
density	NULL
of	NULL
104	NULL
cells/well	NULL
.	NULL

After	NULL
16	NULL
h	NULL
,	NULL
cell	NULL
cultures	NULL
were	NULL
incubated	NULL
with	NULL
TNF	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
16	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

Survival	NULL
was	NULL
assayed	NULL
by	NULL
the	NULL
reduction	NULL
of	NULL
MTT	NULL
and	NULL
calculated	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
staining	NULL
value	NULL
of	NULL
TNF-treated	NULL
and	NULL
untreated	NULL
cultures	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Growth	NULL
inhibition	NULL
.	NULL

HeLa-tat	NULL
cells	NULL
and	NULL
parental	NULL
cells	NULL
were	NULL
seeded	NULL
and	NULL
exposed	NULL
to	NULL
TNF	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Cultures	NULL
were	NULL
incubated	NULL
for	NULL
a	NULL
20	NULL
h	NULL
period	NULL
.	NULL

At	NULL
6	NULL
h	NULL
before	NULL
harvest	NULL
,	NULL
each	NULL
culture	NULL
received	NULL
0.5	NULL
uCi	NULL
[	NULL
}	NULL
HJthymidine	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
lyzed	NULL
with	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
0.1	NULL
N	NULL
HCI	NULL
and	NULL
radioactivity	NULL
was	NULL
counted	NULL
.	NULL

Percent	NULL
growth	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
[	NULL
*H	NULL
Jthymidine	NULL
incorporation	NULL
of	NULL
TNF-treated	NULL
and	NULL
untreated	NULL
cultures	NULL
.	NULL

100	NULL
%	NULL
growth	NULL
corresponds	NULL
to	NULL
73	NULL
795	NULL
c.p.m	NULL
.	NULL

parental	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
HeLa-tat	NULL
cells	NULL
were	NULL
considerably	NULL
more	NULL
susceptible	NULL
to	NULL
growth	NULL
inhibition	NULL
by	NULL
TNF	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
synthetic	NULL
Tat	NULL
(	NULL
sTat	NULL
)	NULL
on	NULL
TNF	NULL
activities	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
that	NULL
extracellular	NULL
Tat	NULL
is	NULL
present	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
HIV-1-infected	NULL
cells	NULL
in	NULL
culture	NULL
(	NULL
Zauli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
HIV-1	NULL
Tat	NULL
can	NULL
enter	NULL
and	NULL
disturb	NULL
non-infected	NULL
cells	NULL
in	NULL
vitro	NULL
and	NULL
also	NULL
possibly	NULL
in	NULL
vivo	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
observed	NULL
effects	NULL
in	NULL
tat-transfected	NULL
cells	NULL
were	NULL
caused	NULL
by	NULL
clonal	NULL
heterogeneity	NULL
,	NULL
experiments	NULL
with	NULL
exogenously	NULL
added	NULL
Tat	NULL
protein	NULL
were	NULL
performed	NULL
.	NULL

Tat	NULL
was	NULL
synthesized	NULL
as	NULL
a	NULL
full-length	NULL
protein	NULL
(	NULL
Kraft	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Control	NULL
experiments	NULL
using	NULL
cells	NULL
transfected	NULL
with	NULL
an	NULL
HIV-1	NULL
LTR	NULL
reporter	NULL
construct	NULL
confirmed	NULL
that	NULL
incubation	NULL
with	NULL
sTat	NULL
had	NULL
transactivating	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
1	NULL
ug/ml	NULL
sTat	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
various	NULL
concentrations	NULL
of	NULL
TNF	NULL
for	NULL
30	NULL
min	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
sTat	NULL
protein	NULL
significantly	NULL
enhanced	NULL
TNF-induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

However	NULL
,	NULL
Tat	NULL
treatment	NULL
alone	NULL
did	NULL
not	NULL
result	NULL
in	NULL
enhanced	NULL
NF-KB	NULL
binding	NULL
activity	NULL
548	NULL
A	NULL
sT	NULL
at	NULL
ais	NULL
.	NULL

«	NULL
i=	NULL
3	NULL
T	NULL
``	NULL
}	NULL
£	NULL
TNF	NULL
=	NULL
0.1	NULL
1	NULL
10	NULL
=-	NULL
0.1	NULL
1	NULL
10	NULL
NF-kB	NULL
a	NULL
U	NULL
=	NULL
-	NULL
up	NULL
NF-kB	NULL
a=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

TNF-induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
after	NULL
treatment	NULL
with	NULL
sTat	NULL
protein	NULL
.	NULL

(	NULL
A	NULL
)	NULL
1	NULL
%	NULL
10°	NULL
HeLa	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
35	NULL
mm	NULL
Petri	NULL
dishes	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
scraped	NULL
off	NULL
the	NULL
plastic	NULL
surface	NULL
in	NULL
0.5	NULL
ml	NULL
PBS	NULL
containing	NULL
1	NULL
ug/ml	NULL
sTat	NULL
at	NULL
4°C	NULL
.	NULL

Then	NULL
2	NULL
ml	NULL
of	NULL
culture	NULL
medium	NULL
were	NULL
added	NULL
and	NULL
the	NULL
incubation	NULL
continued	NULL
.	NULL

After	NULL
16	NULL
h	NULL
,	NULL
TNF	NULL
was	NULL
added	NULL
(	NULL
0.1	NULL
,	NULL
1.0	NULL
and	NULL
10.0	NULL
ng/ml	NULL
)	NULL
.	NULL

After	NULL
a	NULL
further	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
NF-xB	NULL
binding	NULL
activity	NULL
in	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
1	NULL
%	NULL
10°	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
ug/ml	NULL
sTat	NULL
which	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
for	NULL
16	NULL
h.	NULL
Subsequently	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TNF	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
and	NULL
processed	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
higher	NULL
constitutive	NULL
NF-KB	NULL
activity	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
compared	NULL
with	NULL
HeLa	NULL
cells	NULL
may	NULL
be	NULL
due	NULL
to	NULL
clonal	NULL
heterogeneity	NULL
and	NULL
not	NULL
be	NULL
directly	NULL
caused	NULL
by	NULL
Tat	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
Tat	NULL
effects	NULL
observed	NULL
in	NULL
HeLa	NULL
cells	NULL
are	NULL
also	NULL
seen	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
similar	NULL
experiments	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
found	NULL
an	NULL
equally	NULL
strong	NULL
potentiation	NULL
of	NULL
NF-KB	NULL
activity	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
previous	NULL
experiments	NULL
,	NULL
treatment	NULL
with	NULL
sTat	NULL
also	NULL
enhanced	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
TNF	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Maximal	NULL
potentiating	NULL
effects	NULL
were	NULL
observed	NULL
at	NULL
TNF	NULL
concentrations	NULL
between	NULL
0.01	NULL
and	NULL
1.00	NULL
ng/	NULL
mi	NULL
and	NULL
10	NULL
pg/ml	NULL
of	NULL
sTat	NULL
protein	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
,	NULL
like	NULL
other	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
are	NULL
resistant	NULL
against	NULL
the	NULL
cytotoxic	NULL
effect	NULL
of	NULL
TNF	NULL
,	NULL
but	NULL
exhibit	NULL
growth	NULL
inhibition	NULL
in	NULL
response	NULL
to	NULL
TNF	NULL
treatment	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
sTat	NULL
on	NULL
TNF-induced	NULL
proliferation	NULL
inhibition	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
clearly	NULL
demonstrate	NULL
a	NULL
potentiation	NULL
of	NULL
TNF-induced	NULL
growth	NULL
inhibition	NULL
by	NULL
Tat	NULL
,	NULL
even	NULL
at	NULL
concentrations	NULL
where	NULL
TNF	NULL
alone	NULL
had	NULL
only	NULL
small	NULL
inhibitory	NULL
effects	NULL
.	NULL

A	NULL
100	NULL
contro	NULL
!	NULL

-	NULL
&	NULL
-	NULL
1	NULL
pg/ml	NULL
sTat	NULL
T	NULL
“	NULL
80	NULL
-*-	NULL
10	NULL
pg/ml	NULL
sTat	NULL
2	NULL
2	NULL
i	NULL
6	NULL
w	NULL
32	NULL
«	NULL
20	NULL
0	NULL
0,001	NULL
0.01	NULL
01	NULL
1	NULL
10	NULL
100	NULL
TNF	NULL
{	NULL
ng/m	NULL
!	NULL
]	NULL

B	NULL
50	NULL
40	NULL
Eom	NULL
.	NULL

o	NULL
rh	NULL
30	NULL
Le	NULL
}	NULL
b	NULL
.	NULL

&	NULL
20	NULL
a.	NULL
O	NULL
10	NULL
0	NULL
P	NULL
&	NULL
£	NULL
244	NULL
\X	NULL
&	NULL
&	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
sTat	NULL
on	NULL
TNF-induced	NULL
cytotoxicity	NULL
and	NULL
growth	NULL
inhibition	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HeLa	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
96	NULL
microtiter	NULL
wells	NULL
(	NULL
10+	NULL
cells/well	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
1	NULL
or	NULL
10	NULL
ug/ml	NULL
sTat	NULL
.	NULL

After	NULL
16	NULL
h	NULL
cultures	NULL
were	NULL
incubated	NULL
with	NULL
TNF	NULL
.	NULL

Incubation	NULL
was	NULL
continued	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

Survival	NULL
was	NULL
assayed	NULL
by	NULL
the	NULL
reduction	NULL
of	NULL
MTT	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
overnight	NULL
with	NULL
1	NULL
ug/ml	NULL
sTat	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ng/ml	NULL
TNF	NULL
for	NULL
a	NULL
further	NULL
40	NULL
h	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

[	NULL
?	NULL

HJthymidine	NULL
incorporation	NULL
was	NULL
measured	NULL
after	NULL
a	NULL
6	NULL
h	NULL
pulse	NULL
.	NULL

Mean	NULL
values	NULL
and	NULL
standard	NULL
deviations	NULL
of	NULL
triplicate	NULL
samples	NULL
are	NULL
given	NULL
.	NULL

Effects	NULL
of	NULL
endogenously	NULL
produced	NULL
and	NULL
sTat	NULL
protein	NULL
on	NULL
Mn-SOD	NULL
activity	NULL
and	NULL
Mn-SOD-specific	NULL
mRNA	NULL
levels	NULL
It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
both	NULL
the	NULL
gene-inducing	NULL
and	NULL
the	NULL
cytotoxic	NULL
effect	NULL
of	NULL
TNF	NULL
are	NULL
mediated	NULL
by	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
originating	NULL
in	NULL
the	NULL
mitochondrial	NULL
respiratory	NULL
chain	NULL
(	NULL
Schulze-Osthoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Important	NULL
enzymes	NULL
counteracting	NULL
oxidative	NULL
stress	NULL
are	NULL
SODs	NULL
which	NULL
convert	NULL
superoxide	NULL
anion	NULL
(	NULL
O	NULL
,	NULL
~	NULL
)	NULL
to	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
)	NULL
.	NULL

Mn-SOD	NULL
,	NULL
an	NULL
enzyme	NULL
located	NULL
in	NULL
the	NULL
mitochondrial	NULL
matrix	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
various	NULL
agents	NULL
conferring	NULL
oxidative	NULL
stress	NULL
to	NULL
cells	NULL
,	NULL
whereas	NULL
Cu	NULL
,	NULL
Zn-con-taining	NULL
SOD	NULL
(	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
constitutively	NULL
expressed	NULL
(	NULL
Hassan	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
overexpression	NULL
of	NULL
Mn-SOD	NULL
was	NULL
shown	NULL
to	NULL
protect	NULL
cells	NULL
against	NULL
TNF	NULL
cytotoxicity	NULL
(	NULL
Wong	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
SOD	NULL
activity	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
TNF	NULL
effects	NULL
caused	NULL
by	NULL
Tat	NULL
,	NULL
extracts	NULL
of	NULL
parental	NULL
HeLa	NULL
and	NULL
HeLla-tat	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
Mn-SOD	NULL
and	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5A	NULL
,	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
the	NULL
activity	NULL
of	NULL
Mn-SOD	NULL
was	NULL
decreased	NULL
to	NULL
~50	NULL
%	NULL
of	NULL
the	NULL
level	NULL
measured	NULL
in	NULL
parental	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
cell	NULL
types	NULL
contained	NULL
Modulation	NULL
of	NULL
TNF	NULL
effects	NULL
by	NULL
Tat	NULL
A	NULL
1,254	NULL
E	NULL
Cu	NULL
,	NULL
Zn-SC	NULL
.C	NULL
L1	NULL
Mn-SO	NULL
[	NULL
o	NULL
0	NULL
14	NULL
a	NULL
.	NULL

&	NULL
E	NULL
0,754	NULL
G	NULL
8	NULL
0,57	NULL
2	NULL
'	NULL
C	NULL
0,257	NULL
>	NULL
|	NULL
O-HeLa	NULL
HeLa-tat	NULL
B	NULL
C	NULL
D	NULL
HeLa	NULL
cells	NULL
Jurkat	NULL
cells	NULL
>	NULL
+	NULL
-	NULL
+	NULL
>	NULL
+	NULL
transfected	NULL
soluble	NULL
Tat	NULL
tat	NULL
E	NULL
#	NULL
100	NULL
@	NULL
o	NULL
C	NULL
0	NULL
0	NULL
6	NULL
yo	NULL
807	NULL
C	NULL
@	NULL
o	NULL
2	NULL
604	NULL
o	NULL
O	NULL
&	NULL
S	NULL
404	NULL
x1	NULL
``	NULL
10	NULL
6	NULL
10°	NULL
10	NULL
®16	NULL
``	NULL
0	NULL
s	NULL
Tat	NULL
(	NULL
ug/m	NULL
!	NULL
)	NULL

Fig	NULL
.	NULL

5	NULL
.	NULL

Activities	NULL
of	NULL
Mn-SOD	NULL
and	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
,	NULL
and	NULL
dot	NULL
blot	NULL
analysis	NULL
of	NULL
Mn-SOD	NULL
expression	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Activities	NULL
of	NULL
SODs	NULL
.	NULL

Cell	NULL
extracts	NULL
of	NULL
parental	NULL
HeLa	NULL
and	NULL
HeLa-tat	NULL
cells	NULL
(	NULL
1	NULL
%	NULL
10°	NULL
)	NULL
were	NULL
prepared	NULL
by	NULL
sonication	NULL
.	NULL

The	NULL
values	NULL
(	NULL
given	NULL
in	NULL
U/mg	NULL
of	NULL
protein	NULL
)	NULL
are	NULL
the	NULL
means	NULL
of	NULL
three	NULL
independent	NULL
determinations	NULL
.	NULL

(	NULL
B-D	NULL
)	NULL
Dot	NULL
blot	NULL
analysis	NULL
of	NULL
Mn-SOD	NULL
expression	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
(	NULL
1	NULL
%	NULL
10°	NULL
cells	NULL
,	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
dotted	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
human	NULL
Mn-SOD	NULL
,	NULL
washed	NULL
again	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
90	NULL
min	NULL
with	NULL
peroxidase-labeled	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
.	NULL

Signals	NULL
were	NULL
developed	NULL
employing	NULL
the	NULL
enhanced	NULL
chemoluminescence	NULL
reaction	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Dose-dependent	NULL
suppression	NULL
of	NULL
Mn-SOD	NULL
protein	NULL
expression	NULL
by	NULL
sTat	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
scrape-loaded	NULL
with	NULL
sTat	NULL
at	NULL
the	NULL
given	NULL
concentrations	NULL
and	NULL
incubated	NULL
for	NULL
18	NULL
h	NULL
before	NULL
harvest	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
were	NULL
used	NULL
for	NULL
dot	NULL
blot	NULL
analysis	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
,	NULL
and	NULL
quantified	NULL
by	NULL
densitometry	NULL
.	NULL

Results	NULL
are	NULL
given	NULL
as	NULL
percent	NULL
Mn-SOD	NULL
protein	NULL
expression	NULL
of	NULL
an	NULL
untreated	NULL
control	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
sTat	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
was	NULL
inactivated	NULL
by	NULL
oxidation	NULL
.	NULL

Cell	NULL
cultures	NULL
incubated	NULL
with	NULL
oxidized	NULL
Tat	NULL
showed	NULL
Mn-SOD	NULL
activities	NULL
similar	NULL
to	NULL
untreated	NULL
control	NULL
cultures	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

549	NULL
M.O.Westendorp	NULL
et	NULL
al	NULL
.	NULL

&	NULL
5	NULL
x	NULL
$	NULL
a	NULL
«	NULL
b	NULL
D	NULL
d	NULL
D	NULL
CC	NULL
q	NULL
y	NULL
``	NULL
aP	NULL
TNF	NULL
+	NULL
-	NULL
£	NULL
+	NULL
<	NULL
-	NULL
C	NULL
C6	NULL
&	NULL
2	NULL
transfected	NULL
Tat	NULL
TNF	NULL
-	NULL
-	NULL
+	NULL
sTat	NULL
=	NULL
+	NULL
*	NULL
+	NULL
4.0	NULL
kb	NULL
.	NULL

.	NULL

#	NULL
8	NULL
Cu-Zn-SOD	NULL
0.7	NULL
kb	NULL
j	NULL
0.5	NULL
kb	NULL
``	NULL
.	NULL

soluble	NULL
Tat	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
Tat	NULL
on	NULL
Mn-SOD	NULL
and	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
transcription	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Expression	NULL
of	NULL
SOD	NULL
mRNA	NULL
in	NULL
HeLa-tat	NULL
and	NULL
parental	NULL
cells	NULL
.	NULL

2X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
tissue	NULL
flasks	NULL
and	NULL
treated	NULL
with	NULL
10	NULL
ng/ml	NULL
TNF	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
4	NULL
h	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

Samples	NULL
(	NULL
20	NULL
ug	NULL
RNA	NULL
)	NULL
were	NULL
submitted	NULL
to	NULL
electrophoresis	NULL
on	NULL
agarose-formaldehyde	NULL
gels	NULL
and	NULL
hybridized	NULL
with	NULL
cDNA	NULL
probes	NULL
coding	NULL
for	NULL
human	NULL
Mn-SOD	NULL
and	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
.	NULL

Mn-SOD	NULL
RNA	NULL
levels	NULL
of	NULL
HeLa-tat	NULL
cells	NULL
compared	NULL
with	NULL
HeLa	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
densitometry	NULL
were	NULL
28	NULL
(	NULL
-	NULL
TNF	NULL
)	NULL
and	NULL
33	NULL
%	NULL
(	NULL
+	NULL
TNF	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
SOD	NULL
mRNA	NULL
in	NULL
HeLa	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
sTat	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
20	NULL
h	NULL
with	NULL
sTat	NULL
protein	NULL
(	NULL
1	NULL
jig/ml	NULL
)	NULL
.	NULL

Then	NULL
cultures	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
TNF	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
4	NULL
h.	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
and	NULL
hybridized	NULL
with	NULL
radiolabeled	NULL
Mn-SOD	NULL
and	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
cDNA	NULL
probes	NULL
.	NULL

Mn-SOD	NULL
RNA	NULL
levels	NULL
of	NULL
Tat-treated	NULL
HeLa	NULL
cells	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
densitometry	NULL
were	NULL
33	NULL
(	NULL
-	NULL
TNF	NULL
)	NULL
and	NULL
32	NULL
%	NULL
(	NULL
+	NULL
TNF	NULL
)	NULL
.	NULL

similar	NULL
activities	NULL
of	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
.	NULL

This	NULL
decrease	NULL
in	NULL
Mn-SOD	NULL
activity	NULL
was	NULL
found	NULL
to	NULL
correspond	NULL
to	NULL
reduced	NULL
protein	NULL
expression	NULL
.	NULL

Dot	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
antibody	NULL
against	NULL
Mn-SOD	NULL
revealed	NULL
that	NULL
Mn-SOD	NULL
expression	NULL
was	NULL
significantly	NULL
lower	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
incubated	NULL
with	NULL
sTat	NULL
cells	NULL
than	NULL
in	NULL
parental	NULL
HeLa	NULL
cells	NULL
or	NULL
HeLa	NULL
cells	NULL
incubated	NULL
without	NULL
sTat	NULL
(	NULL
Figure	NULL
5B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Similar	NULL
effects	NULL
were	NULL
observed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
sTat	NULL
(	NULL
Figure	NULL
5D	NULL
)	NULL
.	NULL

Figure	NULL
5E	NULL
shows	NULL
that	NULL
the	NULL
suppression	NULL
of	NULL
Mn-SOD	NULL
protein	NULL
expression	NULL
by	NULL
sTat	NULL
is	NULL
dose-dependent	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
suppressed	NULL
Mn-SOD	NULL
activity	NULL
was	NULL
caused	NULL
by	NULL
a	NULL
decreased	NULL
transcription	NULL
of	NULL
the	NULL
Mn-SOD	NULL
gene	NULL
,	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
both	NULL
cell	NULL
types	NULL
was	NULL
examined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6A	NULL
,	NULL
the	NULL
steady	NULL
state	NULL
level	NULL
of	NULL
Mn-SOD	NULL
mRNA	NULL
was	NULL
reduced	NULL
to	NULL
~30	NULL
%	NULL
of	NULL
normal	NULL
levels	NULL
,	NULL
whereas	NULL
mRNA	NULL
expression	NULL
of	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
revealed	NULL
no	NULL
significant	NULL
changes	NULL
.	NULL

The	NULL
transcription	NULL
of	NULL
both	NULL
enzymes	NULL
was	NULL
not	NULL
altered	NULL
significantly	NULL
by	NULL
treatment	NULL
with	NULL
TNF	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
similar	NULL
reduction	NULL
in	NULL
Mn-SOD	NULL
mRNA	NULL
expression	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
HeLa	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
sTat	NULL
protein	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

Full-length	NULL
,	NULL
two-exon	NULL
Tat	NULL
(	NULL
86	NULL
amino	NULL
acids	NULL
long	NULL
,	NULL
Tat	NULL
;	NULL
_s4	NULL
)	NULL
is	NULL
required	NULL
to	NULL
repress	NULL
MHC	NULL
class	NULL
I	NULL
gene	NULL
promoter	NULL
activity	NULL
(	NULL
Howcroft	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
while	NULL
truncated	NULL
Tat	NULL
(	NULL
Tat	NULL
;	NULL
_	NULL
;	NULL
;	NULL
)	NULL
is	NULL
sufficient	NULL
to	NULL
transactivate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
Kuppuswamy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

To	NULL
define	NULL
the	NULL
structural	NULL
features	NULL
of	NULL
HIV-1	NULL
Tat	NULL
required	NULL
to	NULL
suppress	NULL
Mn-SOD	NULL
expression	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
full-length	NULL
Tat	NULL
;	NULL
_s4	NULL
and	NULL
truncated	NULL
Tat	NULL
;	NULL
_	NULL
;	NULL
;	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
,	NULL
only	NULL
Tat	NULL
;	NULL
34	NULL
decreased	NULL
Mn-SOD	NULL
expression	NULL
,	NULL
whereas	NULL
Tat	NULL
;	NULL
_	NULL
;	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

However	NULL
,	NULL
an	NULL
HIV-1	NULL
LTR/CAT	NULL
reporter	NULL
gene	NULL
construct	NULL
transfected	NULL
550	NULL
\	NULL
-p	NULL
£	NULL
18	NULL
3	NULL
cP	NULL
A2	NULL
:	NULL
A	NULL
o	NULL
©	NULL
0	NULL
o	NULL
©	NULL
0	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
full-length	NULL
two-exon	NULL
Tat	NULL
(	NULL
Tat	NULL
;	NULL
_g4	NULL
)	NULL
and	NULL
truncated	NULL
one-exon	NULL
Tat	NULL
(	NULL
Tat	NULL
;	NULL
_	NULL
;	NULL
;	NULL
)	NULL
on	NULL
Mn-SOD	NULL
expression	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
20	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ug/ml	NULL
or	NULL
Tat	NULL
;	NULL
_7	NULL
;	NULL
,	NULL
respectively	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
(	NULL
10°	NULL
cells	NULL
,	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
dotted	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
and	NULL
blots	NULL
developed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
5.	NULL
into	NULL
HeLa	NULL
cells	NULL
was	NULL
transactivated	NULL
equally	NULL
well	NULL
by	NULL
both	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
repression	NULL
of	NULL
Mn-SOD	NULL
gene	NULL
expression	NULL
,	NULL
like	NULL
MHC	NULL
class	NULL
I	NULL
expression	NULL
,	NULL
requires	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
HIV-1	NULL
Tat	NULL
.	NULL

They	NULL
further	NULL
suggest	NULL
a	NULL
common	NULL
mechanism	NULL
of	NULL
gene	NULL
repression	NULL
by	NULL
Tat	NULL
distinct	NULL
from	NULL
HIV-1	NULL
gene	NULL
transactivation	NULL
.	NULL

GSH	NULL
[	NULL
ng	NULL
/	NULL
Mio	NULL
.	NULL

cells	NULL
]	NULL
HeLa	NULL
HeLa-tat	NULL
Jurkat	NULL
Jurkat	NULL
+sTat	NULL
Ratio	NULL
of	NULL
GSH	NULL
/	NULL
GSSG	NULL
&	NULL
HeLa	NULL
HeLa-tat	NULL
Jurkat	NULL
Jurkat	NULL
+sTat	NULL
Modulation	NULL
of	NULL
TNF	NULL
effects	NULL
by	NULL
Tat	NULL
100	NULL
A	NULL
80	NULL
60	NULL
GSH	NULL
content	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
40	NULL
o	NULL
10	NULL
%	NULL
10	NULL
?	NULL

10	NULL
%	NULL
10°	NULL
Tat	NULL
;	NULL
.	NULL

;	NULL
,	NULL
sTat	NULL
(	NULL
ug/ml	NULL
)	NULL
D	NULL
__	NULL
100	NULL
o	NULL
T	NULL
8	NULL
so	NULL
0C	NULL
x	NULL
~~	NULL
60	NULL
T	NULL
©	NULL
&	NULL
g	NULL
40	NULL
(	NULL
1/3	NULL
A	NULL
5	NULL
20	NULL
o	NULL
10	NULL
%	NULL
102	NULL
10	NULL
``	NULL
10°	NULL
Hela-sTat	NULL
(	NULL
ug/ml	NULL
)	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
HIV-1	NULL
Tat	NULL
on	NULL
total	NULL
glutathione	NULL
content	NULL
and	NULL
ratio	NULL
of	NULL
GSH	NULL
:	NULL
GSSG	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Glutathione	NULL
in	NULL
total	NULL
cell	NULL
lysates	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
transfected	NULL
with	NULL
(	NULL
HeLa-tat	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
Tat	NULL
(	NULL
+	NULL
sTat	NULL
)	NULL
was	NULL
assayed	NULL
by	NULL
an	NULL
enzymatic	NULL
recycling	NULL
procedure	NULL
in	NULL
which	NULL
it	NULL
is	NULL
sequentially	NULL
oxidized	NULL
by	NULL
5,5'-dithiobis-	NULL
(	NULL
2-nitrobenzoic	NULL
acid	NULL
)	NULL
(	NULL
DTNB	NULL
)	NULL
and	NULL
reduced	NULL
by	NULL
NADPH	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
glutathione	NULL
reductase	NULL
.	NULL

(	NULL
B	NULL
)	NULL
For	NULL
the	NULL
determination	NULL
of	NULL
glutathione	NULL
disulfide	NULL
,	NULL
GSH	NULL
was	NULL
derivatized	NULL
with	NULL
2-vinylpyridine	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
the	NULL
DTNB	NULL
assay	NULL
.	NULL

Values	NULL
are	NULL
given	NULL
as	NULL
the	NULL
means	NULL
of	NULL
three	NULL
independent	NULL
determinations	NULL
.	NULL

(	NULL
D	NULL
and	NULL
C	NULL
)	NULL
HeLa	NULL
and	NULL
HeLa-tat	NULL
cells	NULL
(	NULL
D	NULL
)	NULL
or	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
(	NULL
5	NULL
%	NULL
10°	NULL
)	NULL
pretreated	NULL
for	NULL
20	NULL
h	NULL
with	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
sTat	NULL
were	NULL
incubated	NULL
with	NULL
20	NULL
uM	NULL
monochlorobimane	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Tat	NULL
;	NULL
_7	NULL
;	NULL
,	NULL
truncated	NULL
Tat	NULL
protein	NULL
lacking	NULL
amino	NULL
acids	NULL
73-86	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
ice-cold	NULL
culture	NULL
medium	NULL
.	NULL

Then	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
the	NULL
relative	NULL
glutathione	NULL
content	NULL
was	NULL
estimated	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

Tat	NULL
protein	NULL
decreases	NULL
the	NULL
cellular	NULL
glutathione	NULL
content	NULL
and	NULL
lowers	NULL
the	NULL
GSH	NULL
:	NULL
GSSG	NULL
ratio	NULL
A	NULL
likely	NULL
consequence	NULL
of	NULL
decreased	NULL
SOD	NULL
activity	NULL
is	NULL
increased	NULL
oxidative	NULL
stress	NULL
reflected	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
glutathione	NULL
or	NULL
a	NULL
decreased	NULL
ratio	NULL
of	NULL
reduced	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
to	NULL
oxidized	NULL
glutathione	NULL
(	NULL
GSSG	NULL
)	NULL
.	NULL

GSH	NULL
,	NULL
an	NULL
important	NULL
antioxidant	NULL
within	NULL
cells	NULL
,	NULL
serves	NULL
as	NULL
a	NULL
substrate	NULL
in	NULL
the	NULL
reduction	NULL
of	NULL
peroxides	NULL
catalyzed	NULL
by	NULL
the	NULL
seleno-enzyme	NULL
glutathione	NULL
peroxidase	NULL
(	NULL
Meister	NULL
and	NULL
Anderson	NULL
,	NULL
1983	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
GSH	NULL
acts	NULL
as	NULL
a	NULL
scavenger	NULL
for	NULL
hydroxyl	NULL
radicals	NULL
.	NULL

We	NULL
measured	NULL
the	NULL
influence	NULL
of	NULL
HIV-1	NULL
Tat	NULL
on	NULL
the	NULL
total	NULL
content	NULL
of	NULL
glutathione	NULL
and	NULL
the	NULL
ratio	NULL
of	NULL
GSH	NULL
:	NULL
GSSG	NULL
in	NULL
both	NULL
HeLa	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
8A	NULL
,	NULL
the	NULL
total	NULL
GSH	NULL
content	NULL
present	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
was	NULL
decreased	NULL
to	NULL
~50	NULL
%	NULL
of	NULL
control	NULL
cells	NULL
The	NULL
ratio	NULL
of	NULL
GSH	NULL
:	NULL
GSSG	NULL
was	NULL
~9.0	NULL
in	NULL
the	NULL
parental	NULL
cells	NULL
and	NULL
6.5	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
(	NULL
Figure	NULL
8B	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
TNF	NULL
slightly	NULL
lowered	NULL
glutathione	NULL
content	NULL
and	NULL
GSH	NULL
:	NULL
GSSG	NULL
ratios	NULL
.	NULL

The	NULL
above	NULL
results	NULL
in	NULL
HeLa-tat	NULL
cells	NULL
were	NULL
confirmed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
treated	NULL
with	NULL
sTat	NULL
(	NULL
Figure	NULL
8A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
8C	NULL
,	NULL
the	NULL
treatment	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
sTat	NULL
protein	NULL
decreased	NULL
the	NULL
glutathione	NULL
content	NULL
in	NULL
a	NULL
dose	NULL
dependent	NULL
manner	NULL
from	NULL
93	NULL
%	NULL
at	NULL
5	NULL
ng/ml	NULL
Tat	NULL
to	NULL
45	NULL
%	NULL
at	NULL
1	NULL
ug/ml	NULL
sTat	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
fluorescence	NULL
intensity	NULL
.	NULL

The	NULL
decrease	NULL
of	NULL
GSH	NULL
levels	NULL
in	NULL
HeLa	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
sTat	NULL
(	NULL
Figure	NULL
8D	NULL
)	NULL
was	NULL
even	NULL
more	NULL
pronounced	NULL
than	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
treatment	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
truncated	NULL
Tat	NULL
;	NULL
;	NULL
;	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
GSH	NULL
content	NULL
(	NULL
Figure	NULL
8C	NULL
)	NULL
.	NULL

Discussion	NULL
Several	NULL
reports	NULL
have	NULL
demonstrated	NULL
previously	NULL
that	NULL
TNF	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
progression	NULL
of	NULL
AIDS	NULL
(	NULL
for	NULL
a	NULL
review	NULL
see	NULL
Rosenberg	NULL
and	NULL
Fauci	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
TNF	NULL
have	NULL
been	NULL
observed	NULL
in	NULL
sera	NULL
and	NULL
in	NULL
supernatants	NULL
of	NULL
monocytes	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
alveolar	NULL
macrophages	NULL
from	NULL
AIDS	NULL
patients	NULL
.	NULL

TNF	NULL
levels	NULL
were	NULL
shown	NULL
to	NULL
become	NULL
progressively	NULL
elevated	NULL
with	NULL
disease	NULL
progression	NULL
towards	NULL
AIDS	NULL
(	NULL
Lachdevirta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
TNF	NULL
is	NULL
known	NULL
to	NULL
stimulate	NULL
HIV-1	NULL
gene	NULL
expression	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
(	NULL
Duh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
which	NULL
is	NULL
modulated	NULL
by	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
(	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Schulze-Osthoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Since	NULL
virus	NULL
replication	NULL
is	NULL
increased	NULL
by	NULL
TNF	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
HIV-1	NULL
gene	NULL
products	NULL
could	NULL
also	NULL
control	NULL
TNF	NULL
activity	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
HIV-1	NULL
Tat	NULL
to	NULL
modulate	NULL
TNF-induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

We	NULL
used	NULL
HeLa	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
rat	NULL
gene	NULL
and	NULL
found	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
Tat	NULL
protein	NULL
enhanced	NULL
NF-KB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
TNF	NULL
.	NULL

Similarly	NULL
,	NULL
synthetic	NULL
Tat	NULL
protein	NULL
,	NULL
when	NULL
added	NULL
to	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
HeLa	NULL
cells	NULL
,	NULL
potentiated	NULL
TNF-induced	NULL
NF-xB	NULL
activation	NULL
and	NULL
TNF-mediated	NULL
cell	NULL
death	NULL
.	NULL

551	NULL
M.O.Westendorp	NULL
et	NULL
al	NULL
.	NULL

Tat-modulated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
by	NULL
TNF	NULL
was	NULL
inhibited	NULL
by	NULL
antioxidants	NULL
such	NULL
as	NULL
BHA	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
Tat	NULL
is	NULL
linked	NULL
to	NULL
cellular	NULL
redox	NULL
state	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
influence	NULL
of	NULL
Tat	NULL
on	NULL
Mn-SOD	NULL
,	NULL
an	NULL
enzyme	NULL
which	NULL
serves	NULL
as	NULL
the	NULL
primary	NULL
defense	NULL
of	NULL
cells	NULL
against	NULL
oxygen-derived	NULL
free	NULL
radicals	NULL
.	NULL

Two	NULL
human	NULL
genes	NULL
encode	NULL
intracellular	NULL
SOD	NULL
proteins	NULL
:	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
Mn-dependent	NULL
SOD	NULL
and	NULL
that	NULL
for	NULL
the	NULL
Cu	NULL
,	NULL
Zn-dependent	NULL
SOD	NULL
.	NULL

Only	NULL
the	NULL
former	NULL
is	NULL
known	NULL
to	NULL
be	NULL
inducible	NULL
and	NULL
regulated	NULL
by	NULL
diverse	NULL
oxidative	NULL
stress-inducing	NULL
agents	NULL
(	NULL
McCord	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1977	NULL
;	NULL
Wong	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
HIV-1	NULL
Tat	NULL
,	NULL
produced	NULL
intracellularly	NULL
or	NULL
added	NULL
exogenously	NULL
,	NULL
strongly	NULL
reduced	NULL
Mn-SOD	NULL
protein	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
Mn-SOD	NULL
RNA	NULL
levels	NULL
were	NULL
strongly	NULL
decreased	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
fat	NULL
(	NULL
see	NULL
also	NULL
Wong	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Flores	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Unlike	NULL
Mn-SOD	NULL
,	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
was	NULL
not	NULL
affected	NULL
significantly	NULL
.	NULL

Similarly	NULL
,	NULL
sTat	NULL
added	NULL
exogenously	NULL
to	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
HeLa	NULL
cells	NULL
decreased	NULL
Mn-SOD	NULL
transcription	NULL
.	NULL

Therefore	NULL
,	NULL
HIV-1	NULL
Tat	NULL
produced	NULL
and	NULL
released	NULL
by	NULL
HIV-l-infected	NULL
cells	NULL
can	NULL
potentially	NULL
influence	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
of	NULL
surrounding	NULL
non-infected	NULL
cells	NULL
.	NULL

To	NULL
shed	NULL
light	NULL
on	NULL
the	NULL
mechanism	NULL
of	NULL
Mn-SOD	NULL
repression	NULL
by	NULL
HIV-1	NULL
Tat	NULL
,	NULL
we	NULL
employed	NULL
a	NULL
mutant	NULL
lacking	NULL
the	NULL
C-terminus	NULL
of	NULL
Tat	NULL
(	NULL
amino	NULL
acid	NULL
positions	NULL
73-86	NULL
)	NULL
which	NULL
is	NULL
encoded	NULL
by	NULL
the	NULL
second	NULL
exon	NULL
of	NULL
the	NULL
tat	NULL
gene	NULL
.	NULL

This	NULL
truncated	NULL
protein	NULL
(	NULL
Tati_	NULL
;	NULL
;	NULL
)	NULL
contains	NULL
all	NULL
elements	NULL
required	NULL
for	NULL
HIV-1	NULL
gene	NULL
transactivation	NULL
(	NULL
Kuppuswamy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
experiments	NULL
clearly	NULL
demonstrate	NULL
that	NULL
Tat	NULL
;	NULL
;	NULL
,	NULL
does	NULL
not	NULL
repress	NULL
Mn-SOD	NULL
gene	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
C-terminal	NULL
sequence	NULL
encoded	NULL
by	NULL
the	NULL
second	NULL
exon	NULL
of	NULL
the	NULL
tat	NULL
gene	NULL
is	NULL
required	NULL
for	NULL
this	NULL
Tat	NULL
activity	NULL
.	NULL

Similar	NULL
observations	NULL
have	NULL
been	NULL
reported	NULL
previously	NULL
for	NULL
the	NULL
repression	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
gene	NULL
expression	NULL
by	NULL
Tat	NULL
(	NULL
Howcroft	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
repression	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
HIV-1	NULL
Tat	NULL
is	NULL
based	NULL
on	NULL
a	NULL
distinct	NULL
mechanism	NULL
which	NULL
,	NULL
unlike	NULL
transactivation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
,	NULL
requires	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
Tat	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Tat-induced	NULL
down-regulation	NULL
of	NULL
Mn-SOD	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
HeLa-tat	NULL
cells	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
decreased	NULL
glutathione	NULL
content	NULL
and	NULL
by	NULL
a	NULL
decreased	NULL
ratio	NULL
of	NULL
GSH	NULL
:	NULL
GSSG	NULL
.	NULL

Such	NULL
an	NULL
imbalance	NULL
of	NULL
the	NULL
antioxidant	NULL
defense	NULL
system	NULL
enhances	NULL
the	NULL
susceptibility	NULL
of	NULL
cells	NULL
towards	NULL
the	NULL
cytotoxic	NULL
action	NULL
of	NULL
TNF	NULL
(	NULL
Wong	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Schulze-Osthoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
this	NULL
assumption	NULL
,	NULL
we	NULL
found	NULL
that	NULL
HIV-1	NULL
Tat	NULL
potentiated	NULL
both	NULL
the	NULL
cytotoxic	NULL
action	NULL
of	NULL
TNF	NULL
and	NULL
its	NULL
inhibitory	NULL
effect	NULL
on	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
Figures	NULL
2	NULL
and	NULL
4B	NULL
)	NULL
.	NULL

In	NULL
line	NULL
with	NULL
the	NULL
observed	NULL
effect	NULL
on	NULL
Mn-SOD	NULL
expression	NULL
,	NULL
Tat	NULL
;	NULL
;	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
GSH	NULL
content	NULL
(	NULL
Figure	NULL
8D	NULL
)	NULL
and	NULL
TNF-mediated	NULL
cytotoxicity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
Tat	NULL
modulates	NULL
TNF	NULL
activity	NULL
by	NULL
the	NULL
following	NULL
mechanisms	NULL
.	NULL

Inhibition	NULL
of	NULL
Mn-SOD	NULL
synthesis	NULL
by	NULL
Tat	NULL
leads	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
superoxide	NULL
anion	NULL
concentration	NULL
.	NULL

Superoxide	NULL
is	NULL
a	NULL
poorly	NULL
reactive	NULL
radical	NULL
and	NULL
may	NULL
diffuse	NULL
in	NULL
the	NULL
cell	NULL
before	NULL
it	NULL
encounters	NULL
an	NULL
appropriate	NULL
reaction	NULL
partner	NULL
.	NULL

Such	NULL
partners	NULL
may	NULL
include	NULL
metal	NULL
ions	NULL
such	NULL
as	NULL
Fe**	NULL
which	NULL
becomes	NULL
reduced	NULL
to	NULL
Fe*	NULL
ions	NULL
.	NULL

Fe®*	NULL
catalyzes	NULL
the	NULL
production	NULL
of	NULL
the	NULL
highly	NULL
reactive	NULL
hydroxyl	NULL
radicals	NULL
that	NULL
give	NULL
rise	NULL
to	NULL
secondary	NULL
reactive	NULL
products	NULL
such	NULL
as	NULL
peroxides	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
peroxides	NULL
are	NULL
counteracted	NULL
by	NULL
glutathione	NULL
peroxidase	NULL
.	NULL

This	NULL
enzyme	NULL
depletes	NULL
reduced	NULL
stores	NULL
of	NULL
glutathione	NULL
.	NULL

A	NULL
decrease	NULL
in	NULL
reduced	NULL
glutathione	NULL
may	NULL
result	NULL
in	NULL
a	NULL
state	NULL
of	NULL
generalized	NULL
552	NULL
induction	NULL
of	NULL
cytotoxicity	NULL
NF-kB	NULL
HIV-1	NULL
activation	NULL
E	NULL
D	NULL
TAT	NULL
Mn-SOD	NULL
downregulation	NULL
t	NULL
oxidative	NULL
stress	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

Proposed	NULL
interrelationship	NULL
between	NULL
Tat	NULL
,	NULL
TNF	NULL
and	NULL
oxidative	NULL
stress	NULL
in	NULL
HIV-1	NULL
infection	NULL
.	NULL

oxidative	NULL
stress	NULL
that	NULL
amplifies	NULL
TNF	NULL
activity	NULL
including	NULL
TNF-induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
TNF-induced	NULL
cytotoxicity	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
TNF	NULL
production	NULL
is	NULL
progressively	NULL
increased	NULL
during	NULL
HIV-1	NULL
infection	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
suspect	NULL
that	NULL
a	NULL
positive	NULL
feed-back	NULL
loop	NULL
may	NULL
exist	NULL
between	NULL
Tat	NULL
protein	NULL
and	NULL
TNF	NULL
that	NULL
stimulates	NULL
rapid	NULL
progression	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
Tat	NULL
,	NULL
the	NULL
cellular	NULL
redox	NULL
system	NULL
and	NULL
TNF	NULL
relevant	NULL
to	NULL
disease	NULL
progression	NULL
in	NULL
AIDS	NULL
is	NULL
depicted	NULL
in	NULL
Figure	NULL
9	NULL
.	NULL

During	NULL
the	NULL
initial	NULL
infection	NULL
HIV-1	NULL
invades	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
such	NULL
as	NULL
macrophages	NULL
,	NULL
and	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
cellular	NULL
genes	NULL
including	NULL
the	NULL
TNF	NULL
gene	NULL
.	NULL

TNF	NULL
then	NULL
stimulates	NULL
HIV-1	NULL
replication	NULL
and	NULL
Tat	NULL
production	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
.	NULL

Tat	NULL
induces	NULL
oxidative	NULL
stress	NULL
which	NULL
further	NULL
enhances	NULL
the	NULL
activity	NULL
of	NULL
TNF	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
incapable	NULL
of	NULL
repairing	NULL
the	NULL
ensuing	NULL
oxidative	NULL
stress	NULL
are	NULL
primed	NULL
to	NULL
undergo	NULL
cell	NULL
death	NULL
(	NULL
Fauci	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

A	NULL
consequence	NULL
of	NULL
these	NULL
events	NULL
might	NULL
be	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
immunological	NULL
effector	NULL
functions	NULL
.	NULL

Tat	NULL
is	NULL
secreted	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
(	NULL
Zauli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
is	NULL
also	NULL
taken	NULL
up	NULL
by	NULL
non-infected	NULL
cells	NULL
(	NULL
Frankel	NULL
and	NULL
Pabo	NULL
,	NULL
1988	NULL
;	NULL
Westendorp	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
speculated	NULL
that	NULL
these	NULL
mechanisms	NULL
also	NULL
occur	NULL
in	NULL
vivo	NULL
.	NULL

Thus	NULL
,	NULL
Tat-producing	NULL
and	NULL
surrounding	NULL
non-infected	NULL
cells	NULL
might	NULL
be	NULL
similarly	NULL
affected	NULL
,	NULL
undergo	NULL
a	NULL
change	NULL
in	NULL
redox	NULL
state	NULL
and	NULL
become	NULL
more	NULL
susceptible	NULL
to	NULL
infection	NULL
or	NULL
the	NULL
cytotoxic	NULL
action	NULL
of	NULL
cytokines	NULL
.	NULL

A	NULL
vicious	NULL
cycle	NULL
may	NULL
lead	NULL
to	NULL
a	NULL
steady	NULL
increase	NULL
of	NULL
TNF	NULL
and	NULL
Tat	NULL
and	NULL
to	NULL
a	NULL
decrease	NULL
of	NULL
antioxidants	NULL
such	NULL
as	NULL
reduced	NULL
glutathione	NULL
.	NULL

These	NULL
events	NULL
might	NULL
finally	NULL
cause	NULL
a	NULL
severe	NULL
aggravation	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

The	NULL
link	NULL
between	NULL
Tat	NULL
and	NULL
TNF	NULL
action	NULL
and	NULL
sulfhydryl	NULL
consumption	NULL
may	NULL
also	NULL
account	NULL
for	NULL
the	NULL
decreased	NULL
glutathione	NULL
levels	NULL
observed	NULL
in	NULL
sera	NULL
of	NULL
HIV-1-infected	NULL
patients	NULL
(	NULL
Gmiinder	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
HIV-1	NULL
has	NULL
found	NULL
mechanisms	NULL
that	NULL
stimulate	NULL
its	NULL
own	NULL
reproduction	NULL
.	NULL

These	NULL
mechanisms	NULL
involve	NULL
the	NULL
control	NULL
of	NULL
the	NULL
cellular	NULL
redox	NULL
system	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
increased	NULL
amounts	NULL
of	NULL
oxidants	NULL
.	NULL

The	NULL
understanding	NULL
of	NULL
the	NULL
interaction	NULL
between	NULL
TNF	NULL
,	NULL
Tat	NULL
protein	NULL
and	NULL
the	NULL
cellular	NULL
redox	NULL
system	NULL
may	NULL
open	NULL
new	NULL
ways	NULL
for	NULL
therapeutic	NULL
intervention	NULL
in	NULL
AIDS	NULL
.	NULL

These	NULL
may	NULL
include	NULL
drugs	NULL
that	NULL
interfere	NULL
with	NULL
Tat	NULL
activity	NULL
(	NULL
Zapp	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
or	NULL
antioxidants	NULL
,	NULL
such	NULL
as	NULL
N-acetyl-cysteine	NULL
,	NULL
which	NULL
replenish	NULL
depleted	NULL
glutathione	NULL
levels	NULL
and	NULL
restore	NULL
a	NULL
normal	NULL
cellular	NULL
redox	NULL
state	NULL
(	NULL
Droge	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cell	NULL
culture	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
HEPES	NULL
(	NULL
0.02	NULL
M	NULL
)	NULL
and	NULL
50	NULL
ug/ml	NULL
gentamycin	NULL
.	NULL

HeLa	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
an	NULL
HIV-1	NULL
tat	NULL
expression	NULL
vector	NULL
(	NULL
Valerie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
were	NULL
subcloned	NULL
twice	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
HIV-1	NULL
tat	NULL
was	NULL
determined	NULL
by	NULL
transient	NULL
transfection	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
construct	NULL
driven	NULL
by	NULL
the	NULL
HIV	NULL
LTR	NULL
enhancer	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
(	NULL
Gorman	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
CAT	NULL
construct	NULL
in	NULL
HeLa	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
rat	NULL
gene	NULL
(	NULL
HeLa-tat	NULL
cells	NULL
)	NULL
was	NULL
~1200-fold	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
parental	NULL
HeLa	NULL
cell	NULL
line	NULL
.	NULL

Materials	NULL
rTNF	NULL
with	NULL
an	NULL
activity	NULL
of	NULL
5x10	NULL
``	NULL
U/mg	NULL
protein	NULL
was	NULL
provided	NULL
by	NULL
BASF	NULL
(	NULL
Ludwigshafen	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

A	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
recognizing	NULL
human	NULL
Mn-SOD	NULL
was	NULL
obtained	NULL
from	NULL
Bender	NULL
(	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
.	NULL

A	NULL
CAT	NULL
reporter	NULL
gene	NULL
construct	NULL
carrying	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
NF-KB	NULL
binding	NULL
motif	NULL
(	NULL
4X	NULL
NF-xB/CAT	NULL
;	NULL
Westendorp	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
was	NULL
used	NULL
for	NULL
the	NULL
transient	NULL
transfection	NULL
of	NULL
HeLa	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
sTat	NULL
The	NULL
synthesis	NULL
of	NULL
full-length	NULL
HIV-1	NULL
Tat	NULL
(	NULL
86	NULL
amino	NULL
acids	NULL
,	NULL
HIV-1	NULL
strain	NULL
BL	NULL
16	NULL
)	NULL
will	NULL
be	NULL
described	NULL
elsewhere	NULL
(	NULL
Kraft	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

A	NULL
mutant	NULL
of	NULL
HIV-1	NULL
Tat	NULL
comprising	NULL
the	NULL
first	NULL
72	NULL
amino	NULL
acid	NULL
positions	NULL
(	NULL
Tat_	NULL
;	NULL
>	NULL
)	NULL
was	NULL
synthesized	NULL
accordingly	NULL
.	NULL

The	NULL
biological	NULL
activity	NULL
of	NULL
both	NULL
sTat	NULL
proteins	NULL
was	NULL
determined	NULL
by	NULL
treatment	NULL
with	NULL
sTat	NULL
of	NULL
HeLa	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
HIV-1	NULL
LTR-driven	NULL
CAT	NULL
reporter	NULL
gene	NULL
construct	NULL
,	NULL
followed	NULL
by	NULL
assaying	NULL
CAT	NULL
activity	NULL
.	NULL

HeLa	NULL
cells	NULL
'scrape-loaded	NULL
'	NULL
(	NULL
Gentz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
with	NULL
1	NULL
ug/ml	NULL
sTat	NULL
showed	NULL
an	NULL
~680-fold	NULL
higher	NULL
LTR	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
HeLa	NULL
cells	NULL
'scrape-loaded	NULL
'	NULL
with	NULL
1	NULL
ug/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
ability	NULL
of	NULL
sTat	NULL
to	NULL
influence	NULL
TNF-mediated	NULL
cytotoxicity	NULL
and	NULL
proliferation	NULL
inhibition	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
ng/ml	NULL
to	NULL
10	NULL
ug/ml	NULL
sTat	NULL
for	NULL
4-24	NULL
h	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
modulation	NULL
of	NULL
TNF-induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
the	NULL
protein	NULL
,	NULL
sTat	NULL
was	NULL
introduced	NULL
into	NULL
HeLa	NULL
cells	NULL
by	NULL
'scrape	NULL
loading	NULL
'	NULL
.	NULL

Briefly	NULL
,	NULL
1X	NULL
10°	NULL
HeLa	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
35	NULL
mm	NULL
Petri	NULL
dishes	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
and	NULL
scraped	NULL
off	NULL
the	NULL
plastic	NULL
surface	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
cold	NULL
PBS	NULL
(	NULL
4°C	NULL
)	NULL
containing	NULL
1	NULL
or	NULL
10	NULL
pg/ml	NULL
sTat	NULL
.	NULL

Then	NULL
2	NULL
ml	NULL
of	NULL
culture	NULL
medium	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
suspension	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
at	NULL
37°C	NULL
.	NULL

In	NULL
one	NULL
experiment	NULL
sTat	NULL
was	NULL
inactivated	NULL
by	NULL
exposing	NULL
the	NULL
protein	NULL
solution	NULL
to	NULL
a	NULL
flow	NULL
of	NULL
molecular	NULL
oxygen	NULL
.	NULL

Proliferation	NULL
and	NULL
cytotoxicity	NULL
assay	NULL
The	NULL
cytotoxic	NULL
activity	NULL
of	NULL
TNF	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
colorimetric	NULL
assay	NULL
(	NULL
MTT	NULL
test	NULL
;	NULL
Sladowski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1x	NULL
10	NULL
%	NULL
cells	NULL
per	NULL
well	NULL
in	NULL
96-well	NULL
flat-bottomed	NULL
microtiter	NULL
plates	NULL
and	NULL
incubated	NULL
for	NULL
16	NULL
h	NULL
in	NULL
0.2	NULL
ml	NULL
culture	NULL
medium	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
then	NULL
removed	NULL
and	NULL
replaced	NULL
by	NULL
fresh	NULL
medium	NULL
containing	NULL
serial	NULL
dilutions	NULL
of	NULL
TNF	NULL
and	NULL
actinomycin	NULL
D	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

Incubation	NULL
was	NULL
continued	NULL
for	NULL
16	NULL
h	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
10	NULL
ul	NULL
of	NULL
an	NULL
MTT	NULL
solution	NULL
(	NULL
5	NULL
mg/ml	NULL
PBS	NULL
)	NULL
.	NULL

After	NULL
another	NULL
4	NULL
h	NULL
incubation	NULL
,	NULL
supernatants	NULL
were	NULL
removed	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
150	NULL
ul	NULL
of	NULL
a	NULL
solution	NULL
containing	NULL
4	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
HCI	NULL
and	NULL
96	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
isopropanol	NULL
.	NULL

The	NULL
absorbance	NULL
of	NULL
each	NULL
well	NULL
was	NULL
determined	NULL
with	NULL
an	NULL
automated	NULL
plate	NULL
reader	NULL
(	NULL
SLT	NULL
Easy	NULL
Reader	NULL
EAR	NULL
400	NULL
AT	NULL
,	NULL
Crailsheim	NULL
,	NULL
Germany	NULL
)	NULL
at	NULL
550	NULL
nm	NULL
.	NULL

Survival	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
staining	NULL
value	NULL
of	NULL
untreated	NULL
cultures	NULL
.	NULL

Percent	NULL
cytotoxicity	NULL
is	NULL
the	NULL
difference	NULL
between	NULL
control	NULL
(	NULL
100	NULL
%	NULL
)	NULL
and	NULL
percent	NULL
survival	NULL
.	NULL

Proliferation	NULL
was	NULL
measured	NULL
by	NULL
[	NULL
*H	NULL
thymidine	NULL
incorporation	NULL
(	NULL
0.5	NULL
uCi	NULL
,	NULL
specific	NULL
activity	NULL
185	NULL
GBq/mMol	NULL
;	NULL
Amersham	NULL
,	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
the	NULL
last	NULL
6	NULL
h	NULL
of	NULL
a	NULL
20	NULL
h	NULL
culture	NULL
period	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
lyzed	NULL
with	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
0.1	NULL
N	NULL
HCI	NULL
and	NULL
radioactivity	NULL
was	NULL
counted	NULL
.	NULL

Determination	NULL
of	NULL
SOD	NULL
activity	NULL
SOD	NULL
was	NULL
assayed	NULL
by	NULL
the	NULL
cytochrome	NULL
c	NULL
method	NULL
(	NULL
McCord	NULL
and	NULL
Fridovich	NULL
,	NULL
1969	NULL
)	NULL
.	NULL

The	NULL
two	NULL
forms	NULL
of	NULL
SOD	NULL
(	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
and	NULL
Mn-SOD	NULL
)	NULL
were	NULL
distinguished	NULL
by	NULL
their	NULL
differential	NULL
sensitivity	NULL
to	NULL
cyanide	NULL
.	NULL

Intracellular	NULL
GSH	NULL
and	NULL
GSSG	NULL
measurement	NULL
GSH	NULL
and	NULL
GSSG	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Griffith	NULL
,	NULL
1980	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
GSH	NULL
was	NULL
estimated	NULL
using	NULL
FACS	NULL
analysis	NULL
Modulation	NULL
of	NULL
TNF	NULL
effects	NULL
by	NULL
Tat	NULL
of	NULL
monochlorobimane-stained	NULL
cells	NULL
(	NULL
Staal	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Cells	NULL
kept	NULL
in	NULL
culture	NULL
medium	NULL
were	NULL
loaded	NULL
with	NULL
20	NULL
uM	NULL
monochlorobimane	NULL
(	NULL
Molecular	NULL
Probes	NULL
Inc.	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
,	NULL
USA	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
ice-cold	NULL
medium	NULL
.	NULL

Then	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
cold	NULL
PBS	NULL
;	NULL
FACS	NULL
measurement	NULL
was	NULL
performed	NULL
immediately	NULL
after	NULL
staining	NULL
using	NULL
the	NULL
FACS	NULL
Vantage	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
the	NULL
excitation	NULL
set	NULL
at	NULL
351-364	NULL
nm	NULL
and	NULL
the	NULL
emission	NULL
filter	NULL
at	NULL
450	NULL
nm	NULL
(	NULL
Omega	NULL
450	NULL
DF-65	NULL
)	NULL
.	NULL

Dead	NULL
cells	NULL
were	NULL
excluded	NULL
by	NULL
forward-and	NULL
side-scatter	NULL
gating	NULL
;	NULL
mean	NULL
values	NULL
from	NULL
duplicate	NULL
samples	NULL
were	NULL
considered	NULL
for	NULL
data	NULL
analysis	NULL
.	NULL

Dot	NULL
blot	NULL
analysis	NULL
Total	NULL
cell	NULL
lysates	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
,	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
dotted	NULL
onto	NULL
a	NULL
HybondTM	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
in	NULL
log	NULL
2	NULL
dilutions	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
washed	NULL
six	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
incubated	NULL
with	NULL
a	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
against	NULL
human	NULL
Mn-SOD	NULL
,	NULL
washed	NULL
six	NULL
times	NULL
as	NULL
described	NULL
above	NULL
,	NULL
incubated	NULL
for	NULL
90	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
1:4000	NULL
diluted	NULL
peroxidase-labeled	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Dianova	NULL
,	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
washed	NULL
again	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Signals	NULL
were	NULL
developed	NULL
using	NULL
the	NULL
enhanced	NULL
chemoluminescence	NULL
reaction	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
_	NULL
(	NULL
Amersham	NULL
)	NULL
;	NULL
_	NULL
autoradiographs	NULL
_	NULL
were	NULL
-	NULL
quantified	NULL
densitometrically	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
according	NULL
to	NULL
Chirgwin	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
incubated	NULL
for	NULL
18	NULL
h	NULL
with	NULL
HIV-1	NULL
Tat	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
TNF	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
another	NULL
4	NULL
h.	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
employing	NULL
1	NULL
%	NULL
formaldehyde-agarose	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
by	NULL
capillary	NULL
blotting	NULL
and	NULL
fixed	NULL
by	NULL
UV	NULL
irradiation	NULL
.	NULL

Hybridization	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
42°C	NULL
in	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
pyrophosphate	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
0.2	NULL
%	NULL
polyvinylpyrrolidone	NULL
,	NULL
0.2	NULL
%	NULL
Ficoll	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
%	NULL
BSA	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
and	NULL
50	NULL
%	NULL
formamide	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
to	NULL
a	NULL
stringency	NULL
of	NULL
0.5	NULL
%	NULL
SSC	NULL
(	NULL
SSC	NULL
:	NULL
15	NULL
mM	NULL
sodium	NULL
citrate	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
)	NULL
)	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
62°C	NULL
,	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
an	NULL
X-ray	NULL
film	NULL
at	NULL
70°C	NULL
.	NULL

A	NULL
650	NULL
bp	NULL
fragment	NULL
of	NULL
human	NULL
Mn-SOD	NULL
cDNA	NULL
and	NULL
a	NULL
600	NULL
bp	NULL
fragment	NULL
of	NULL
human	NULL
Cu	NULL
,	NULL
Zn-SOD	NULL
cDNA	NULL
were	NULL
labeled	NULL
with	NULL
*°P	NULL
and	NULL
used	NULL
as	NULL
hybridization	NULL
probes	NULL
(	NULL
Amstad	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Autoradiographs	NULL
were	NULL
quantified	NULL
densitometrically	NULL
.	NULL

Preparation	NULL
of	NULL
total	NULL
cell	NULL
extracts	NULL
Cells	NULL
(	NULL
1X10°	NULL
per	NULL
sample	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
TNF	NULL
for	NULL
30	NULL
min	NULL
as	NULL
indicated	NULL
,	NULL
harvested	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
high	NULL
salt	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
MgC1	NULL
;	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
0.5	NULL
mM	NULL
DDT	NULL
,	NULL
10	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
and	NULL
0.001	NULL
%	NULL
aprotinin	NULL
.	NULL

After	NULL
15	NULL
min	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
lysates	NULL
were	NULL
centrifuged	NULL
and	NULL
supernatants	NULL
were	NULL
transferred	NULL
to	NULL
new	NULL
vials	NULL
and	NULL
kept	NULL
frozen	NULL
at	NULL
-70°C	NULL
.	NULL

EMSAs	NULL
EMSAs	NULL
were	NULL
performed	NULL
as	NULL
follows	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
extracts	NULL
(	NULL
10	NULL
pug	NULL
protein	NULL
,	NULL
determined	NULL
by	NULL
a	NULL
protein	NULL
assay	NULL
kit	NULL
;	NULL
Bio-Rad	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
NF-xB-specific	NULL
+°P-labeled	NULL
oligonucleotide	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
double-stranded	NULL
30	NULL
bp	NULL
probe	NULL
comprising	NULL
the	NULL
NF-KB	NULL
site	NULL
and	NULL
flanking	NULL
sequences	NULL
from	NULL
the	NULL
mouse	NULL
kappa	NULL
light	NULL
chain	NULL
enhancer	NULL
is	NULL
shown	NULL
in	NULL
Zabel	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
20	NULL
ul	NULL
volume	NULL
containing	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
2	NULL
ug	NULL
BSA	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
DDT	NULL
,	NULL
2.5	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
4	NULL
%	NULL
Ficoll	NULL
and	NULL
3000-6000	NULL
c.p.m	NULL
.	NULL

of	NULL
the	NULL
random	NULL
primer-labeled	NULL
oligonucleotide	NULL
.	NULL

After	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
samples	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
non-denaturing	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
run	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
buffer	NULL
at	NULL
pH	NULL
8.0	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
overnight	NULL
to	NULL
a	NULL
Kodak	NULL
X-ray	NULL
film	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
M.Kraft	NULL
,	NULL
K.Hexel	NULL
and	NULL
D.HeiB	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Bundesministerium	NULL
fiir	NULL
Forschung	NULL
und	NULL
Technologie	NULL
,	NULL
Bonn	NULL
,	NULL
Germany	NULL
.	NULL

References	NULL
Ameisen	NULL
,	NULL
J.C	NULL
.	NULL

and	NULL
Capron	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
,	NULL
12	NULL
,	NULL
102-105	NULL
.	NULL

Amstad.P	NULL
.	NULL

,	NULL
Peskin	NULL
,	NULL
A.	NULL
,	NULL
Mirault	NULL
,	NULL
M.E	NULL
.	NULL

,	NULL
Moret	NULL
,	NULL
R.	NULL
,	NULL
Zbinden,1	NULL
.	NULL

and	NULL
Cerutti	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochemistry	NULL
,	NULL
30	NULL
,	NULL
9305-9313	NULL
.	NULL

553	NULL
M.O.Westendorp	NULL
et	NULL
al	NULL
.	NULL

Banda	NULL
,	NULL
N.K	NULL
.	NULL

,	NULL
Bemier	NULL
,	NULL
J.	NULL
,	NULL
Kurahara	NULL
,	NULL
D.K	NULL
.	NULL

,	NULL
Kurie.R	NULL
.	NULL

,	NULL
Haigwood	NULL
,	NULL
N.	NULL
,	NULL
Sekaly	NULL
,	NULL
R.P	NULL
.	NULL

and	NULL
Finkel	NULL
,	NULL
T.H	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
176	NULL
,	NULL
1099-1106	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
,	NULL
63-80	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
,	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
Silverman	NULL
,	NULL
R.H	NULL
.	NULL

and	NULL
Jeang.K.-T.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
59	NULL
,	NULL
273-282	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
242	NULL
,	NULL
135-140	NULL
.	NULL

Buonaguro	NULL
,	NULL
L.	NULL
,	NULL
Barillari	NULL
,	NULL
G.	NULL
,	NULL
Chang	NULL
,	NULL
HK	NULL
.	NULL

,	NULL
Bohan	NULL
,	NULL
C	NULL
.	NULL

A.	NULL
,	NULL
Kao	NULL
,	NULL
V.	NULL
,	NULL
Morgan	NULL
,	NULL
R.	NULL
,	NULL
Gallo	NULL
,	NULL
R.C	NULL
.	NULL

and	NULL
Ensoli	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
7159-7167	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Przybyla	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
MacDonald	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Rutter	NULL
,	NULL
(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
,	NULL
18	NULL
,	NULL
5294-5299	NULL
.	NULL

Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
,	NULL
46	NULL
,	NULL
973-982	NULL
.	NULL

Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
63	NULL
,	NULL
655-657	NULL
.	NULL

Dingwall	NULL
,	NULL
C	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
6925-6929	NULL
.	NULL

Drioge	NULL
,	NULL
W.	NULL
,	NULL
Eck	NULL
,	NULL
H.-P.	NULL
and	NULL
Mihm	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
,	NULL
13	NULL
,	NULL
211-214	NULL
.	NULL

Duh	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
Maury	NULL
,	NULL
W.J	NULL
.	NULL

,	NULL
Folks	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Fauci	NULL
,	NULL
A.S	NULL
.	NULL

and	NULL
Rabson	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
5974-5978	NULL
.	NULL

Fauci	NULL
,	NULL
A.S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
,	NULL
262	NULL
,	NULL
1011-1018	NULL
.	NULL

Feinberg.M.B	NULL
.	NULL

,	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Frankel	NULL
,	NULL
A.D.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
4045-4049	NULL
.	NULL

Flores	NULL
,	NULL
S.C.	NULL
,	NULL
Marecki	NULL
,	NULL
J.C.	NULL
,	NULL
Harper	NULL
,	NULL
K.P	NULL
.	NULL

,	NULL
Bose	NULL
,	NULL
S.K	NULL
.	NULL

,	NULL
Nelson	NULL
,	NULL
S.K	NULL
.	NULL

and	NULL
McCord	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
7632-7636	NULL
.	NULL

Folks	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Clouse	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
Justement	NULL
,	NULL
J.	NULL
,	NULL
Rabson	NULL
,	NULL
A.	NULL
,	NULL
Duh	NULL
,	NULL
E.	NULL
,	NULL
Kehrl	NULL
,	NULL
J.H	NULL
.	NULL

and	NULL
Fauci	NULL
,	NULL
A.S.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
2365-2368	NULL
.	NULL

Frankel	NULL
,	NULL
A.D.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
2	NULL
,	NULL
293-298	NULL
.	NULL

Frankel	NULL
,	NULL
A.D.	NULL
and	NULL
Pabo	NULL
,	NULL
C.O	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
,	NULL
55	NULL
,	NULL
1189-1193	NULL
.	NULL

Gentz	NULL
,	NULL
R.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
821-824	NULL
.	NULL

Gmiinder	NULL
,	NULL
H.	NULL
,	NULL
Eck	NULL
,	NULL
H.-P.	NULL
,	NULL
Benninghoff	NULL
,	NULL
B.	NULL
,	NULL
Roth	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Drige	NULL
,	NULL
W	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
32-46	NULL
.	NULL

Gorman	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
In	NULL
Glower	NULL
,	NULL
D.M	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
DNA	NULL
Cloning	NULL
.	NULL

IRF	NULL
Press	NULL
,	NULL
Washington	NULL
,	NULL
DC	NULL
,	NULL
Vol	NULL
.	NULL

II	NULL
,	NULL
pp	NULL
.	NULL

143-160	NULL
.	NULL

Gougeon	NULL
,	NULL
M.L	NULL
.	NULL

and	NULL
Montagnier	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
,	NULL
260	NULL
,	NULL
1269-1272	NULL
.	NULL

Griffith	NULL
,	NULL
O.W	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
106	NULL
,	NULL
207-212	NULL
.	NULL

Hassan	NULL
,	NULL
H.M	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Free	NULL
Radic	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
5	NULL
,	NULL
377-385	NULL
.	NULL

Hauber	NULL
,	NULL
J.	NULL
,	NULL
Perkins	NULL
,	NULL
A.	NULL
,	NULL
Heimer	NULL
,	NULL
E.P	NULL
.	NULL

and	NULL
Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
,	NULL
6367-6368	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
L.	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

and	NULL
Baeuerie	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
,	NULL
365	NULL
,	NULL
182-185	NULL
.	NULL

Howcroft	NULL
,	NULL
T.K	NULL
.	NULL

,	NULL
Strebel	NULL
,	NULL
K.	NULL
,	NULL
Martin	NULL
,	NULL
M.A	NULL
.	NULL

and	NULL
Singer	NULL
,	NULL
D.S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
,	NULL
260	NULL
,	NULL
1320-1322	NULL
.	NULL

Huber	NULL
,	NULL
B.E	NULL
.	NULL

,	NULL
Richards	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Martin	NULL
,	NULL
J.L	NULL
.	NULL

and	NULL
Wirth	NULL
,	NULL
PJ	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Carcinogen	NULL
.	NULL

,	NULL
5	NULL
,	NULL
293-300	NULL
.	NULL

Kraft	NULL
,	NULL
M.	NULL
,	NULL
Westendorp	NULL
,	NULL
M.O	NULL
.	NULL

,	NULL
Krammer	NULL
,	NULL
PH	NULL
.	NULL

,	NULL
Schuckert,0	NULL
.	NULL

,	NULL
Bayer	NULL
,	NULL
P.	NULL
,	NULL
Rosch	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Frank	NULL
,	NULL
R.W	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
In	NULL
Maia	NULL
,	NULL
H.L	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Peptides	NULL
1994	NULL
.	NULL

Escom	NULL
,	NULL
Leiden	NULL
,	NULL
Belgium	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Krishnan	NULL
,	NULL
V.L	NULL
.	NULL

,	NULL
Meager	NULL
,	NULL
A.	NULL
,	NULL
Mitchell	NULL
,	NULL
D.M	NULL
.	NULL

and	NULL
Pinching	NULL
,	NULL
A.J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
80	NULL
,	NULL
156-160	NULL
.	NULL

Kuppuswamy	NULL
,	NULL
M.	NULL
,	NULL
Subramanian	NULL
,	NULL
T.	NULL
,	NULL
Srinivasan	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Chinadurai	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
,	NULL
3551-3561	NULL
.	NULL

Lachdevirta	NULL
,	NULL
J.	NULL
,	NULL
Maury	NULL
,	NULL
C.P	NULL
.	NULL

,	NULL
Teppo	NULL
,	NULL
A.M.	NULL
and	NULL
Repo	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Am	NULL
.	NULL

J	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
85	NULL
,	NULL
289-291	NULL
.	NULL

Laspia	NULL
,	NULL
M.F	NULL
.	NULL

,	NULL
Rice	NULL
,	NULL
A.P	NULL
.	NULL

and	NULL
Mathews	NULL
,	NULL
M.B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
2397-2408	NULL
.	NULL

Marcuzzi	NULL
,	NULL
A.	NULL
,	NULL
Weinberger	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Weinberger,0.K	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
4228-4232	NULL
.	NULL

McCord	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Fridovich	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1969	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
244	NULL
,	NULL
6049-6055	NULL
.	NULL

McCord	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Boyle	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Day	NULL
,	NULL
E.D..Jr	NULL
,	NULL
Rizzolo	NULL
,	NULL
L.J	NULL
.	NULL

and	NULL
Salin	NULL
,	NULL
M.L	NULL
.	NULL

(	NULL
1977	NULL
)	NULL
In	NULL
Michelson	NULL
,	NULL
A.M.	NULL
,	NULL
McCord	NULL
,	NULL
J.J	NULL
.	NULL

and	NULL
Fridovich	NULL
,	NULL
I	NULL
(	NULL
eds	NULL
)	NULL
,	NULL
Superoxide	NULL
and	NULL
Superoxide	NULL
Dismutase	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
London	NULL
,	NULL
UK	NULL
,	NULL
pp	NULL
.	NULL

129-138	NULL
.	NULL

Meister	NULL
,	NULL
A.	NULL
and	NULL
Anderson	NULL
,	NULL
(	NULL
1983	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
52	NULL
,	NULL
711-760	NULL
.	NULL

Mellors	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
Griffith	NULL
,	NULL
B.P	NULL
.	NULL

,	NULL
Ortiz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Landry	NULL
,	NULL
M.L	NULL
.	NULL

and	NULL
Ryan	NULL
,	NULL
J.L	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

,	NULL
163	NULL
,	NULL
78-82	NULL
.	NULL

Meyaard	NULL
,	NULL
L.	NULL
,	NULL
Oftto	NULL
,	NULL
S.A.	NULL
,	NULL
Jonker	NULL
,	NULL
R.R	NULL
.	NULL

,	NULL
Mijnster	NULL
,	NULL
M.J.	NULL
,	NULL
Keet.R.PM	NULL
.	NULL

and	NULL
Miedema	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
,	NULL
257	NULL
,	NULL
217-219	NULL
.	NULL

Mihm	NULL
,	NULL
S.	NULL
,	NULL
Ennen	NULL
,	NULL
J.	NULL
,	NULL
Pessara	NULL
,	NULL
U.	NULL
,	NULL
Kurth	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Drége	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
AIDS	NULL
,	NULL
5	NULL
,	NULL
497-503	NULL
.	NULL

Osbomn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

Poesik	NULL
,	NULL
E.	NULL
,	NULL
Higuchi	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Aggarwal	NULL
,	NULL
B.B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Lymphokine	NULL
Cytokine	NULL
Res	NULL
.	NULL

,	NULL
11	NULL
,	NULL
317-325	NULL
.	NULL

Purvis	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
Georges	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
Williams	NULL
,	NULL
T.M	NULL
.	NULL

and	NULL
Lederman	NULL
,	NULL
M.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
144	NULL
,	NULL
32-42	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
Staal	NULL
,	NULL
FJ.T	NULL
.	NULL

,	NULL
Raju	NULL
,	NULL
PA.	NULL
,	NULL
Ela	NULL
,	NULL
S.W	NULL
.	NULL

,	NULL
Herzenberg.L.A	NULL
.	NULL

and	NULL
Herzenberg	NULL
,	NULL
L.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
4884-4888	NULL
.	NULL

Rosenberg	NULL
,	NULL
Z.F	NULL
.	NULL

and	NULL
Fauci	NULL
,	NULL
A.S.	NULL
(	NULL
1990	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
,	NULL
11	NULL
,	NULL
176-180	NULL
.	NULL

554	NULL
Scala	NULL
,	NULL
G.	NULL
,	NULL
Ruocco	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Ambrosino	NULL
,	NULL
C.	NULL
,	NULL
Mallardo	NULL
,	NULL
M.	NULL
,	NULL
Giordano	NULL
,	NULL
V.	NULL
,	NULL
Baldassarre	NULL
,	NULL
F.	NULL
,	NULL
Dragonetti	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Venuta	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
179	NULL
,	NULL
961-971	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
2247-2258	NULL
.	NULL

Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
-	NULL
Bakker	NULL
,	NULL
A.C.	NULL
,	NULL
Vanhaesebroeck	NULL
,	NULL
B.	NULL
,	NULL
-	NULL
Beyaert	NULL
,	NULL
R.	NULL
,	NULL
Jacob	NULL
,	NULL
W.A	NULL
.	NULL

and	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
267	NULL
,	NULL
5317-5323	NULL
.	NULL

Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Beyaert.R	NULL
.	NULL

,	NULL
Vandevoorde	NULL
,	NULL
V.	NULL
,	NULL
Haegeman	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
3095-3104	NULL
.	NULL

Sharp	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Marciniak	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
59	NULL
,	NULL
229-230	NULL
.	NULL

Sladowski	NULL
,	NULL
D.	NULL
,	NULL
Steer	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Clothier	NULL
,	NULL
R.H	NULL
.	NULL

and	NULL
Balls	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
,	NULL
157	NULL
,	NULL
203-207	NULL
.	NULL

Southgate	NULL
,	NULL
C.D	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
M.R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
2496-2507	NULL
.	NULL

Staal	NULL
,	NULL
FJ.T	NULL
.	NULL

,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.A	NULL
.	NULL

and	NULL
Herzenberg	NULL
,	NULL
L.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
9943-9947	NULL
.	NULL

Staal	NULL
,	NULL
FJ	NULL
.	NULL

,	NULL
Ela	NULL
,	NULL
S.W	NULL
.	NULL

,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Anderson	NULL
,	NULL
Herzenberg.L.A	NULL
.	NULL

and	NULL
Herzenberg	NULL
,	NULL
L.A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Lancet	NULL
,	NULL
339	NULL
,	NULL
909-912	NULL
.	NULL

Taylor	NULL
,	NULL
J.P.	NULL
,	NULL
Cupp	NULL
,	NULL
C.	NULL
,	NULL
Diaz	NULL
,	NULL
A.	NULL
,	NULL
Chowdhury	NULL
,	NULL
M.	NULL
,	NULL
Khalili	NULL
,	NULL
K.	NULL
,	NULL
Jimenez	NULL
,	NULL
S.A	NULL
.	NULL

and	NULL
Amini	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
,	NULL
9617-9621	NULL
.	NULL

Valerie.K	NULL
.	NULL

,	NULL
Delers	NULL
,	NULL
A.	NULL
,	NULL
Bruck	NULL
,	NULL
C.	NULL
,	NULL
Thiriart	NULL
,	NULL
C.	NULL
,	NULL
Rosenberg	NULL
,	NULL
H.	NULL
,	NULL
Debouck	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Rosenberg	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
333	NULL
,	NULL
78-81	NULL
.	NULL

Viscidi	NULL
,	NULL
R.P	NULL
.	NULL

,	NULL
Mayur	NULL
,	NULL
K.	NULL
,	NULL
Lederman	NULL
,	NULL
H.M	NULL
.	NULL

and	NULL
Frankel	NULL
,	NULL
A.D.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
,	NULL
246	NULL
,	NULL
1606-1608	NULL
.	NULL

Vyakarnam	NULL
,	NULL
A.	NULL
,	NULL
Matear	NULL
,	NULL
P.	NULL
,	NULL
Meager	NULL
,	NULL
A.	NULL
,	NULL
Kelly	NULL
,	NULL
G.	NULL
,	NULL
Stanley	NULL
,	NULL
B.	NULL
,	NULL
Weller	NULL
,	NULL
I	NULL
.	NULL

and	NULL
Beverley	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
84	NULL
,	NULL
109-115	NULL
.	NULL

Westendorp	NULL
,	NULL
M.O	NULL
.	NULL

,	NULL
Li-Weber	NULL
,	NULL
M.	NULL
,	NULL
Frank	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Krammer	NULL
,	NULL
P.H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
68	NULL
,	NULL
4177-4185	NULL
.	NULL

Wong	NULL
,	NULL
G.H.W	NULL
.	NULL

,	NULL
Elwell	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
Oberley	NULL
,	NULL
L	NULL
.	NULL

W.	NULL
and	NULL
Goeddel	NULL
,	NULL
D.V	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
58	NULL
,	NULL
923-931	NULL
.	NULL

Wong	NULL
,	NULL
G.H.W	NULL
.	NULL

,	NULL
McHugh	NULL
,	NULL
T.	NULL
,	NULL
Weber	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Goeddel	NULL
,	NULL
D.V	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
4372-4376	NULL
.	NULL

Wright	NULL
,	NULL
S.C.	NULL
,	NULL
Jewett	NULL
.	NULL

A.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Bonavida	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
141	NULL
,	NULL
99-104	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
Schreck	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
,	NULL
252-260	NULL
.	NULL

Zapp	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
Stern	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
M.R	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
,	NULL
74	NULL
,	NULL
969-978	NULL
.	NULL

Zauli	NULL
,	NULL
G.	NULL
,	NULL
Davis	NULL
,	NULL
B.R	NULL
.	NULL

,	NULL
Re	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Visani	NULL
,	NULL
G.	NULL
,	NULL
Furlini	NULL
,	NULL
G	NULL
.	NULL

and	NULL
La	NULL
Placa	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
,	NULL
80	NULL
,	NULL
3036-3043	NULL
.	NULL

Received	NULL
on	NULL
May	NULL
9	NULL
,	NULL
1994	NULL
;	NULL
revised	NULL
on	NULL
September	NULL
29	NULL
,	NULL
1994	NULL

